# Role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review.

**DOI:** 10.1007/s00213-024-06686-7
**Authors:** ['HalfordWarlick Iv', 'DarcyTocci', 'SukritiPrashar', 'ErickBoldt', 'AlenaKhalil', 'SimranArora', 'ThomasMatthews', 'TalhaWahid', 'RichardFernandez', 'DhiyaRam', 'LexieLeon', 'ArishaArain', 'JoseRey', 'KelleyDavis']
**Journal:** Psychopharmacology
**Year:** 
**Scraped from:** DOI.org
**Scraped by:** agent_b
**Scraping date:** 2025-10-21T11:00:48.135821

## Abstract

The Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) classifies attention deficit hyperactivity disorder (ADHD) as a neurodevelopmental disorder that interferes with human functioning and development. As the clinical presentation of ADHD involves a deficiency in executive function, neurocognitive deficits involving distinctive neuropathological changes must be present for clinical diagnosis.
The vesicular monoamine transporter (VMAT), specifically VMAT-2, plays a role in ADHD pathogenesis. In addition, experimental data show that the stimulants (amphetamines and methylphenidate) are first-line treatments for the condition because of their extensive interaction with VMAT-2. The interactions of peptides, bupropion, and nutritional supplements with VMAT-2 receptors have been researched, but more evidence is needed to elucidate their pharmacodynamic properties. Therefore, this literature review evaluated the current pharmacological treatment modalities, peptides, and nutritional supplements for ADHD that target the VMAT-2 system.
We obtained relevant studies from several platforms, including the National Center for Biotechnology, Clinical Key, Access Medicine, and PubMed. From the results of these studies, we observed that stimulants interact highly with the VMAT-2 transporter, with omega-3 fatty acids, peptides, and bupropion exerting some modulatory activity on VMAT-2. These agents should be considered for the future treatment of ADHD, although clinical-level research involving human participants is necessary.

## Full Text

## Abstract
rationale the diagnostic and statistical manual of mental disorders (fifth edition) classifies attention deficit hyperactivity disorder (adhd) as a neurodevelopmental disorder that interferes with human functioning and development. as the clinical presentation of adhd involves a deficiency in executive function, neurocognitive deficits involving distinctive neuropathological changes must be present for clinical diagnosis. objectives the vesicular monoamine transporter (vmat), specifically vmat-2, plays a role in adhd pathogenesis. in addition, experimental data show that the stimulants (amphetamines and methylphenidate) are first-line treatments for the condition because of their extensive interaction with vmat-2. the interactions of peptides, bupropion, and nutritional supplements with vmat-2 receptors have been researched, but more evidence is needed to elucidate their pharmacodynamic properties. therefore, this literature review evaluated the current pharmacological treatment modalities, peptides, and nutritional supplements for adhd that target the vmat-2 system. methods, results, and conclusions we obtained relevant studies from several platforms, including the national center for biotechnology, clinical key, access medicine, and pubmed. from the results of these studies, we observed that stimulants interact highly with the vmat-2 transporter, with omega-3 fatty acids, peptides, and bupropion exerting some modulatory activity on vmat-2. these agents should be considered for the future treatment of adhd, although clinical-level research involving human participants is necessary. this is a preview of subscription content, log in via an institution to check access. access this article log in via an institution subscribe and save springer+ from $39.99 /month starting from 10 chapters or articles per month access and download chapters and articles from more than 300k books and 2,500 journals cancel anytime view plans buy now buy article pdf usd 39.95 price excludes vat (usa) tax calculation will be finalised during checkout. instant access to the full article pdf. datalayer.push({"ecommerce":{"currency":"usd","impressions":[{"name":"role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review","id":"1432-2072","price":39.95,"brand":"springer berlin heidelberg","category":"neuroscience","variant":"ppv-article","quantity":1}]}}); ;(function () { if (window.localstorage) { window.localstorage.removeitem("springerplusrollout") } })() .springer-plus .buying-option-usps > li::before { background-image: url("data:image/svg+xml,%3csvg viewbox='0 0 100 100' xmlns='http://www.w3.org/2000/svg' fill='%230070a8'%3e%3ccircle cx='50' cy='50' r='50'/%3e%3c/svg%3e"); } institutional subscriptions .sprcom-buybox-articledarwin .buybox__access-option{ border-top: 1px solid #cedbe0; font-size: 1rem; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus{ background-color: #ebf6ff; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus-headline{ display: flex; justify-content: space-between; } .sprcom-buybox-articledarwin .springer-plus-heading{ border-bottom: 1px solid #c5e0f4; border-top: 1px solid #c5e0f4; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; font-size: 1.125rem; font-weight: 700; margin: 0; padding: 16px; text-align: center; } .sprcom-buybox-articledarwin .springer-plus-title{ align-items: center; display: flex; } .sprcom-buybox-articledarwin .springer-plus-title span{ margin-left: 8px; } .sprcom-buybox-articledarwin .springer-plus a{ background-color: #fff; border: 1px solid #025e8d; color: #025e8d; font-size: 16px; font-weight: 700; max-height: 44px; } .sprcom-buybox-articledarwin .springer-plus a span{ margin-right: 8px; } .sprcom-buybox-articledarwin .springer-plus a:hover{ background-color: #025e8d; border: 4px solid #025e8d; box-shadow: none; color: #fff; font-weight: 700; } .sprcom-buybox-articledarwin .springer-plus a:visited{ color: #025e8d; } .sprcom-buybox-articledarwin .springer-plus a:visited:hover{ color: #fff; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps{ color: #555; font-size: 1rem; line-height: 1.6; list-style: none; margin: 0; padding: 16px 0 24px 0; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li{ padding-left: 26px; position: relative; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li::before{ content: ''; height: 10px; left: 0; position: absolute; top: calc(0.8em - 5px); width: 10px; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li:not(:first-child){ margin-top: 4px; } fig. 1 fig. 2 similar content being viewed by others mechanisms of neurotransmitter transport and drug inhibition in human vmat2 article 01 november 2023 transport and inhibition mechanism for vmat2-mediated synaptic vesicle loading of monoamines article open access 02 january 2024 drug inhibition and substrate transport mechanisms of human vmat2 article open access 02 january 2025 window.datalayer = window.datalayer || []; window.datalayer.push({ recommendations: { recommender: 'semantic', model: 'specter', policy_id: 'na', timestamp: 1761044444, embedded_user: 'null' } }); explore related subjects discover the latest articles, books and news in related subjects, suggested using machine learning. adhd attention deficit disorder drug therapy neuropharmacology transporters in the nervous system transport vesicle references adler la, dirks b, deas pf, raychaudhuri a, dauphin mr, lasser ra, weisler rh (2013) lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. j clin psychiatry 74:694–702. https://doi.org/10.4088/jcp.12m08144 article cas pubmed google scholar alwindi m, bizanti a (2023) vesicular monoamine transporter (vmat) regional expression and roles in pathological conditions. heliyon 9:e22413. https://doi.org/10.1016/j.heliyon.2023.e22413 article cas pubmed pubmed central google scholar barlow rb, johnson o (1989) relations between structure and nicotine-like activity: x-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds. br j pharmacol 98:799–808. https://doi.org/10.1111/j.1476-5381.1989.tb14608.x article cas pubmed pubmed central google scholar barragán e, breuer d, döpfner m (2017) efficacy and safety of omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with adhd. j atten disord 21:433–441. https://doi.org/10.1177/1087054713518239 article pubmed google scholar biederman j, fried r, hammerness p, surman c, mehler b, petty cr, faraone sv, miller c, bourgeois m, meller b, godfrey km, reimer b (2012) the effects of lisdexamfetamine dimesylate on the driving performance of young adults with adhd: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. j psychiatr res 46:484–491. https://doi.org/10.1016/j.jpsychires.2012.01.007 article pubmed google scholar blick ska, keating gm (2007) lisdexamfetamine. paediatr drugs 9:129–135 discussion 136. https://doi.org/10.2165/00148581-200709020-00007 article pubmed google scholar blum k, chen alc, braverman er, comings de, chen tjh, arcuri v, blum sh, downs bw, waite rl, notaro a, lubar j, williams l, prihoda tj, palomo t, oscar-berman m (2008) attention-deficit-hyperactivity disorder and reward deficiency syndrome. neuropsychiatr dis treat 4:893–918. https://doi.org/10.2147/ndt.s2627 article pubmed pubmed central google scholar bristot g, ascoli bm, scotton e, géa lp, pfaffenseller b, kauer-sant’anna m (2019) effects of lithium on inflammatory and neurotrophic factors after an immune challenge in a lisdexamfetamine animal model of mania. braz j psychiatry 41:419–427. https://doi.org/10.1590/1516-4446-2017-0001 article pubmed pubmed central google scholar burns c, kidron a (eds) (2022) biochemistry, tyramine. statpearls. internet. in: statpearls publishing, treasure island (fl), p 2024 jan-. https://www.ncbi.nlm.nih.gov/books/nbk563197/ comiran e, kessler fh, fröehlich pe, limberger rp (2016) lisdexamfetamine: a pharmacokinetic review. eur j pharm sci 89:172–179. https://doi.org/10.1016/j.ejps.2016.04.026 article cas pubmed google scholar crooks pa, zheng g, vartak ap, culver jp, zheng f, horton db, dwoskin lp (2011) design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse. curr top med chem 11:1103–1127. https://doi.org/10.2174/156802611795371332 article cas pubmed pubmed central google scholar dhillon s, yang lph, curran mp (2008) bupropion: a review of its use in the management of major depressive disorder. drugs 68:653–689. https://doi.org/10.2165/00003495-200868050-00011 article cas pubmed google scholar di miceli m, derf a, gronier b (2022) consequences of acute or chronic methylphenidate exposure using ex vivo neurochemistry and in vivo electrophysiology in the prefrontal cortex and striatum of rats. int j mol sci 23:8588. https://doi.org/10.3390/ijms23158588 article cas pubmed pubmed central google scholar dupaul gj, weyandt ll, rossi js, vilardo ba, o’dell sm, carson km, verdi g, swentosky a (2012) double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with adhd. j atten disord 16:202–220. https://doi.org/10.1177/1087054711427299 article pubmed google scholar duvall mg, levy bd (2016) dha- and epa-derived resolvins, protectins, and maresins in airway inflammation. eur j pharmacol 785:144–155. https://doi.org/10.1016/j.ejphar.2015.11.001 article cas pubmed google scholar eiden le, weihe e (2011) vmat2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. ann n y acad sci 1216:86–98. https://doi.org/10.1111/j.1749-6632.2010.05906.x article cas pubmed pubmed central google scholar fda (2017) mydayis. https://pi.shirecontent.com/pi/pdfs/mydayis_usa_eng.pdf fda (2009) ritalin. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/010187s077lbl.pdf foley kf, desanty kp, kast re (2006) bupropion: pharmacology and therapeutic applications. expert rev neurother 6:1249–1265. https://doi.org/10.1586/14737175.6.9.1249 article cas pubmed google scholar freyberg z, sonders ms, aguilar ji, hiranita t, karam cs, flores j, pizzo ab, zhang y, farino zj, chen a, martin ca, kopajtic ta, fei h, hu g, lin yy, mosharov ev, mccabe bd, freyberg r, wimalasena k, hsin lw, sames d, krantz de, katz jl, sulzer d, javitch ja (2016) mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in drosophila brain. nat commun 7:10652. https://doi.org/10.1038/ncomms10652 article cas pubmed pubmed central google scholar garey jd, lusskin si, scialli ar (2020) teratogen update: amphetamines. birth defects res 112:1171–1182. https://doi.org/10.1002/bdr2.1774 article cas pubmed google scholar guillot ts, miller gw (2009) protective actions of the vesicular monoamine transporter 2 (vmat2) in monoaminergic neurons. mol neurobiol 39:149–170. https://doi.org/10.1007/s12035-009-8059-y article cas pubmed google scholar guillot ts, richardson jr, wang mz, li yj, taylor tn, ciliax bj, zachrisson o, mercer a, miller gw (2008) pacap38 increases vesicular monoamine transporter 2 (vmat2) expression and attenuates methamphetamine toxicity. neuropeptides 42:423–434. https://doi.org/10.1016/j.npep.2008.04.003 article cas pubmed pubmed central google scholar hauser j, makulska-gertruda e, reissmann a, sontag ta, tucha o, lange kw (2014) the effects of nutritional polyunsaturated fatty acids on locomotor activity in spontaneously hypertensive rats. atten defic hyperact disord 6:61–65. https://doi.org/10.1007/s12402-013-0125-7 article pubmed google scholar healy-stoffel m, levant b (2018) n-3 (omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders. cns neurol disord drug targets 17:216–232. https://doi.org/10.2174/1871527317666180412153612 article cas pubmed pubmed central google scholar heinzerling kg, swanson an, hall tm, yi y, wu y, shoptaw sj (2014) randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use. addiction 109:1878–1886. https://doi.org/10.1111/add.12636 article pubmed pubmed central google scholar hesse lm, venkatakrishnan k, court mh, von moltke ll, duan sx, shader ri, greenblatt dj (2000) cyp2b6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. drug metab dispos 28:1176–1183 cas pubmed google scholar huss m, duhan p, gandhi p, chen cw, spannhuth c, kumar v (2017) methylphenidate dose optimization for adhd treatment: review of safety, efficacy, and clinical necessity. neuropsychiatr dis treat 13:1741–1751. https://doi.org/10.2147/ndt.s130444 article cas pubmed pubmed central google scholar hutson ph, pennick m, secker r (2014) preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug. neuropharmacology 87:41–50. https://doi.org/10.1016/j.neuropharm.2014.02.014 article cas pubmed google scholar iwahashi m, yoshimura t, harigai w, takuma k, hashimoto h, katayama t, hayata-takano a (2023) pituitary adenylate cyclase-activating polypeptide deficient mice show length abnormalities of the axon initial segment. j pharmacol sci 153:175–182. https://doi.org/10.1016/j.jphs.2023.08.006 article cas pubmed google scholar kameg b, fradkin d (2021) management of attention-deficit/hyperactivity disorder in adults. j nurse pract 17:432–436. https://doi.org/10.1016/j.nurpra.2020.11.005 article google scholar kazda l, bell k, thomas r, mcgeechan k, sims r, barratt a (2021) overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic scoping review. jama netw open 4:e215335. https://doi.org/10.1001/jamanetworkopen.2021.5335 article pubmed pubmed central google scholar korchynska s, rebernik p, pende m, boi l, alpár a, tasan r, becker k, balueva k, saghafi s, wulff p, horvath tl, fisone g, dodt hu, hökfelt t, harkany t, romanov ra (2022) a hypothalamic dopamine locus for psychostimulant-induced hyperlocomotion in mice. nat commun 13:5944. https://doi.org/10.1038/s41467-022-33584-3 article cas pubmed pubmed central google scholar li y, yan x, li q, li q, xu g, lu j, yang w (2023) prevalence and trends in diagnosed adhd among us children and adolescents, 2017–2022. jama netw open 6:e2336872. https://doi.org/10.1001/jamanetworkopen.2023.36872 article pubmed pubmed central google scholar lu w, wolf me (1997) expression of dopamine transporter and vesicular monoamine transporter 2 mrnas in rat midbrain after repeated amphetamine administration. brain res mol brain res 49:137–148. https://doi.org/10.1016/s0169-328x(97)00136-8 article cas pubmed google scholar majarwitz dj, perumareddi p (2023) attention-deficit/hyperactivity disorder across the spectrum: from childhood to adulthood. prim care 50:21–36. https://doi.org/10.1016/j.pop.2022.10.004 article pubmed google scholar maneeton n, maneeton b, srisurapanont m, martin sd (2011) bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo‐controlled trials. psychiatry clin neurosci 65:611–617. https://doi.org/10.1111/j.1440-1819.2011.02264.x article pubmed google scholar martin ca, nuzzo pa, ranseen jd, kleven ms, guenthner g, williams y, walsh sl, dwoskin lp (2018) lobeline effects on cognitive performance in adult adhd. j atten disord 22:1361–1366. https://doi.org/10.1177/1087054713497791 article pubmed google scholar metz vg, segat hj, dias vt, barcelos rcs, maurer lh, stiebe j, emanuelli t, burger me, pase cs (2019) omega-3 decreases d1 and d2 receptors expression in the prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats. j nutr biochem 67:182–189. https://doi.org/10.1016/j.jnutbio.2019.02.007 article cas pubmed google scholar najib j (2009) the efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults. clin ther 31:142–176. https://doi.org/10.1016/j.clinthera.2009.01.015 article cas pubmed google scholar najib j, wimer d, zeng j, lam kw, romanyak n, paige morgan e, thadavila a (2017) review of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. j cent nerv syst dis 9:1179573517728090. https://doi.org/10.1177/1179573517728090 article cas pubmed pubmed central google scholar narendran r, frankle wg, mason ns, muldoon mf, moghaddam b (2012) improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation. plos one 7:e46832. https://doi.org/10.1371/journal.pone.0046832 article cas pubmed pubmed central google scholar ng qx (2017) a systematic review of the use of bupropion for attention-deficit/hyperactivity disorder in children and adolescents. j child adolesc psychopharmacol 27:112–116. https://doi.org/10.1089/cap.2016.0124 article cas pubmed google scholar nguyen m, shapiro ma, tharani s (2012) clinical utility of lisdexamfetamine for the management of attention-deficit hyperactivity disorder. clin med insights ther 4. https://doi.org/10.4137/cmt.s8706 nickell jr, siripurapu kb, vartak a, crooks pa, dwoskin lp (2014) the vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. adv pharmacol 69:71–106. https://doi.org/10.1016/b978-0-12-420118-7.00002-0 article cas pubmed pubmed central google scholar partilla js, dempsey ag, nagpal as, blough be, baumann mh, rothman rb (2006) interaction of amphetamines and related compounds at the vesicular monoamine transporter. j pharmacol exp ther 319:237–246. https://doi.org/10.1124/jpet.106.103622 article cas pubmed google scholar perera h, jeewandara kc, seneviratne s, guruge c (2012) combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (adhd) refractory to methylphenidate treatment: a double-blind, placebo-controlled study. j child neurol 27:747–753. https://doi.org/10.1177/0883073811435243 article pubmed google scholar quintero j, gutiérrez-casares jr, álamo c (2022) molecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on adhd neurobiology: a review. neurol ther 11:1489–1517. https://doi.org/10.1007/s40120-022-00392-2 article pubmed pubmed central google scholar rau ks, birdsall e, hanson je, johnson-davis kl, carroll fi, wilkins dg, gibb jw, hanson gr, fleckenstein ae (2005) bupropion increases striatal vesicular monoamine transport. neuropharmacology 49:820–830. https://doi.org/10.1016/j.neuropharm.2005.05.004 article cas pubmed google scholar reese mj, wurm rm, muir kt, generaux gt, st john-williams l, mcconn dj (2008) an in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug–drug interaction. drug metab dispos 36:1198–1201. https://doi.org/10.1124/dmd.107.020198 article cas pubmed google scholar riddle el, hanson gr, fleckenstein ae (2007) therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. eur j pharmacol 571:25–28. https://doi.org/10.1016/j.ejphar.2007.05.044 article cas pubmed pubmed central google scholar sandoval v, riddle el, hanson gr, fleckenstein ae (2002) methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. j neurosci 22:8705–8710. https://doi.org/10.1523/jneurosci.22-19-08705.2002 article cas pubmed pubmed central google scholar schwartz k, weizman a, rehavi m (2006) the effect of psychostimulants on [ 3 h]dopamine uptake and release in rat brain synaptic vesicles. j neural transm (vienna) 113:1347–1352. https://doi.org/10.1007/s00702-005-0383-4 article cas pubmed google scholar stahl sm (2014) stahl’s essential psychopharmacology. cambridge stahl sm, pradko jf, haight br, modell jg, rockett cb, learned-coughlin s (2004) a review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. prim care companion j clin psychiatry 6:159–166. https://doi.org/10.4088/pcc.v06n0403 article pubmed pubmed central google scholar støier jf, konomi-pilkati a, apuschkin m, herborg f, gether u (2023) amphetamine-induced reverse transport of dopamine does not require cytosolic ca 2+ . j biol chem 299:105063. https://doi.org/10.1016/j.jbc.2023.105063 article cas pubmed pubmed central google scholar strawn jr, picard ls (2017) triple-bead mixed amphetamine salt for adhd. curr psychiatry 16:33–37 google scholar sulzer d, rayport s (1990) amphetamine and other psychostimulants reduce ph gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. neuron 5:797–808. https://doi.org/10.1016/0896-6273(90)90339-h article cas pubmed google scholar teng lh, crooks pa, sonsalla pk, dwoskin lp (1997) lobeline and nicotine evoke [ 3 h]overflow from rat striatal slices preloaded with [ 3 h]dopamine: differential inhibition of synaptosomal and vesicular [ 3 h]dopamine uptake. j pharmacol exp ther 280:1432–1444 cas pubmed google scholar teng b, murthy ks, kuemmerle jf, grider jr, makhlouf gm (1998) selective expression of vasoactive intestinal peptide (vip)2/pituitary adenylate cyclase-activating polypeptide (pacap)3 receptors in rabbit and guinea pig gastric and tenia coli smooth muscle cells. regul pept 77:127–134. https://doi.org/10.1016/s0167-0115(98)00112-8 article cas pubmed google scholar toren p, rehavi m, luski a, roz n, laor n, lask m, weizman a (2005) decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder. eur neuropsychopharmacol 15:159–162. https://doi.org/10.1016/j.euroneuro.2004.07.002 article cas pubmed google scholar vaudry d, gonzalez bj, basille m, yon l, fournier a, vaudry h (2000) pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. pharmacol rev 52:269–324 cas pubmed google scholar velasco er, florido a, flores á, senabre e, gomez-gomez a, torres a, roca a, norrholm s, newman el, das p, ross ra, lori a, pozo oj, ressler kj, garcia-esteve ll, jovanovic t, andero r (2022) pacap-pac1r modulates fear extinction via the ventromedial hypothalamus. nat commun 13:4374. https://doi.org/10.1038/s41467-022-31442-w article cas pubmed pubmed central google scholar verbeeck w, bekkering ge, van den noortgate w, kramers c (2017) bupropion for attention deficit hyperactivity disorder (adhd) in adults. cochrane database syst rev 10:cd009504. https://doi.org/10.1002/14651858.cd009504.pub2 article pubmed google scholar wang g, pan j, tan yy, sun xk, zhang yf, zhou hy, ren rj, wang xj, chen sd (2008) neuroprotective effects of pacap27 in mice model of parkinson’s disease involved in the modulation of k(atp) subunits and d2 receptors in the striatum. neuropeptides 42:267–276. https://doi.org/10.1016/j.npep.2008.03.002 article cas pubmed google scholar wimalasena k (2011) vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry. med res rev 31:483–519. https://doi.org/10.1002/med.20187 article cas pubmed google scholar download references acknowledgements we thank editage ( www.editage.com ) for english language editing. funding not applicable. author information authors and affiliations dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa halford warlick iv, sukriti prashar, erick boldt, alena khalil, simran arora, thomas matthews, talha wahid, richard fernandez, dhiya ram &amp; lexie leon dr. kiran c. patel college of allopathic medicine, health profession division, nova southeastern university, fort lauderdale, florida, usa darcy tocci &amp; kelley davis college of pharmacy, health profession division, nova southeastern university, fort lauderdale, florida, usa jose rey halmos college of arts and sciences, nova southeastern university, fort lauderdale, florida, usa arisha arain authors halford warlick iv view author publications search author on: pubmed google scholar darcy tocci view author publications search author on: pubmed google scholar sukriti prashar view author publications search author on: pubmed google scholar erick boldt view author publications search author on: pubmed google scholar alena khalil view author publications search author on: pubmed google scholar simran arora view author publications search author on: pubmed google scholar thomas matthews view author publications search author on: pubmed google scholar talha wahid view author publications search author on: pubmed google scholar richard fernandez view author publications search author on: pubmed google scholar dhiya ram view author publications search author on: pubmed google scholar lexie leon view author publications search author on: pubmed google scholar arisha arain view author publications search author on: pubmed google scholar jose rey view author publications search author on: pubmed google scholar kelley davis view author publications search author on: pubmed google scholar corresponding author correspondence to halford warlick iv . ethics declarations conflict of interest not applicable. additional information publisher’s note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. rights and permissions springer nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. reprints and permissions about this article cite this article warlick iv, h., tocci, d., prashar, s. et al. role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review. psychopharmacology 241 , 2191–2203 (2024). https://doi.org/10.1007/s00213-024-06686-7 download citation received : 19 january 2024 accepted : 05 september 2024 published : 20 september 2024 issue date : november 2024 doi : https://doi.org/10.1007/s00213-024-06686-7 share this article anyone you share the following link with will be able to read this content: get shareable link sorry, a shareable link is not currently available for this article. copy shareable link to clipboard provided by the springer nature sharedit content-sharing initiative keywords attention deficit hyperactivity disorder vesicular monoamine transporter neurodevelopmental disorder amphetamines methylphenidate omega-3 fatty acids bupropion norepinephrine dopamine ph gradient model profiles halford warlick iv view author profile access this article log in via an institution subscribe and save springer+ from $39.99 /month starting from 10 chapters or articles per month access and download chapters and articles from more than 300k books and 2,500 journals cancel anytime view plans buy now buy article pdf usd 39.95 price excludes vat (usa) tax calculation will be finalised during checkout. instant access to the full article pdf. datalayer.push({"ecommerce":{"currency":"usd","impressions":[{"name":"role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review","id":"1432-2072","price":39.95,"brand":"springer berlin heidelberg","category":"neuroscience","variant":"ppv-article","quantity":1}]}}); ;(function () { if (window.localstorage) { window.localstorage.removeitem("springerplusrollout") } })() .springer-plus .buying-option-usps > li::before { background-image: url("data:image/svg+xml,%3csvg viewbox='0 0 100 100' xmlns='http://www.w3.org/2000/svg' fill='%230070a8'%3e%3ccircle cx='50' cy='50' r='50'/%3e%3c/svg%3e"); } institutional subscriptions .sprcom-buybox-articledarwin .buybox__access-option{ border-top: 1px solid #cedbe0; font-size: 1rem; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus{ background-color: #ebf6ff; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus-headline{ display: flex; justify-content: space-between; } .sprcom-buybox-articledarwin .springer-plus-heading{ border-bottom: 1px solid #c5e0f4; border-top: 1px solid #c5e0f4; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; font-size: 1.125rem; font-weight: 700; margin: 0; padding: 16px; text-align: center; } .sprcom-buybox-articledarwin .springer-plus-title{ align-items: center; display: flex; } .sprcom-buybox-articledarwin .springer-plus-title span{ margin-left: 8px; } .sprcom-buybox-articledarwin .springer-plus a{ background-color: #fff; border: 1px solid #025e8d; color: #025e8d; font-size: 16px; font-weight: 700; max-height: 44px; } .sprcom-buybox-articledarwin .springer-plus a span{ margin-right: 8px; } .sprcom-buybox-articledarwin .springer-plus a:hover{ background-color: #025e8d; border: 4px solid #025e8d; box-shadow: none; color: #fff; font-weight: 700; } .sprcom-buybox-articledarwin .springer-plus a:visited{ color: #025e8d; } .sprcom-buybox-articledarwin .springer-plus a:visited:hover{ color: #fff; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps{ color: #555; font-size: 1rem; line-height: 1.6; list-style: none; margin: 0; padding: 16px 0 24px 0; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li{ padding-left: 26px; position: relative; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li::before{ content: ''; height: 10px; left: 0; position: absolute; top: calc(0.8em - 5px); width: 10px; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li:not(:first-child){ margin-top: 4px; } advertisement window.sn = window.sn || {}; window.sn.libs = window.sn.libs || {}; window.sn.libs.ads = window.sn.libs.ads || {}; window.sn.libs.ads.slotconfig = window.sn.libs.ads.slotconfig || {}; window.sn.libs.ads.slotconfig['mpu1'] = { 'pos': 'mpu1', 'type': 'mpu1', }; window.sn.libs.ads.slotconfig['unitpath'] = '/270604982/springerlink/213/article'; search search by keyword or author search navigation find a journal publish with us track your research discover content journals a-z books a-z publish with us journal finder publish your research language editing open access publishing products and services our products librarians societies partners and advertisers our brands springer nature portfolio bmc palgrave macmillan apress discover your privacy choices/manage cookies your us state privacy rights accessibility statement terms and conditions privacy policy help and support legal notice cancel contracts here 52.88.153.61 not affiliated &copy; 2025 springer nature

## Introduction
#fff;color:#222;font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;line-height:1.8;min-height:100%}a{color:#025e8d;padding:initial;text-decoration:underline;text-decoration-skip-ink:auto}button{cursor:pointer}img{border:0;height:auto;max-width:100%;vertical-align:middle}html{box-sizing:border-box;font-size:100%;height:100%;overflow-y:scroll}h1{font-size:2.25rem}h2{font-size:1.75rem}h1,h2,h3{font-weight:700;line-height:1.2}h3{font-size:1.5rem}body{font-size:1.125rem}*{box-sizing:inherit}p{margin-bottom:2rem;margin-top:0}p:last-of-type{margin-bottom:0}.c-ad{text-align:center}@media only screen and (min-width:480px){.c-ad{padding:8px}}.c-ad--728x90{display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:876px){.js .c-ad--728x90{display:none}}.c-ad__label,.c-status-message{font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif}.c-ad__label{color:#333;font-size:.875rem;font-weight:400;line-height:1.5;margin-bottom:4px}.c-status-message{align-items:center;box-sizing:border-box;display:flex;position:relative;width:100%}.c-status-message--boxed{background-color:#fff;border:1px solid #ccc;line-height:1.4;padding:16px}.c-status-message__heading{font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;font-size:1rem;font-weight:700}.c-status-message__icon{fill:currentcolor;display:inline-block;flex:0 0 auto;height:1.5em;margin-right:8px;transform:translate(0);vertical-align:text-top;width:1.5em}.c-status-message__icon--top{align-self:flex-start}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-status-message--error .c-status-message__icon{color:#c40606}.c-status-message--boxed.c-status-message--error{border-bottom:4px solid #c40606}.c-status-message--success .c-status-message__icon{color:#00b8b0}.c-status-message--boxed.c-status-message--success{border-bottom:4px solid #00b8b0}.c-status-message--warning .c-status-message__icon{color:#edbc53}.c-status-message--boxed.c-status-message--warning{border-bottom:4px solid #edbc53}.c-status-message :last-child{margin-bottom:0}.eds-c-button{border-radius:32px;cursor:pointer;display:inline-block;font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;font-size:1rem;font-weight:700;line-height:1.5;margin:0;padding:.5rem 1.5rem;position:relative;text-align:center;text-decoration:none;transition:all .2s ease 0s;width:100%}.eds-c-button span,.eds-c-button svg{vertical-align:middle}.eds-c-button svg{height:1.5rem;width:1.5rem}.eds-c-button svg:first-child{margin-right:8px}@media only screen and (min-width:480px){.eds-c-button{width:auto}}.eds-c-button--primary{background-color:#025e8d;background-image:none;border:2px solid transparent;box-shadow:none;color:#fff;text-decoration:none}.eds-c-button--primary svg{fill:currentcolor}.eds-c-header{background-color:#fff;border-bottom:2px solid #01324b;font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;font-size:1rem;line-height:1.5;padding:8px 0 0}.eds-c-header__container{align-items:center;display:flex;flex-wrap:nowrap;gap:8px 16px;justify-content:space-between;margin:0 auto 8px;max-width:1280px;padding:0 8px;position:relative}.eds-c-header__nav{border-top:2px solid #c5e0f4;padding-top:4px;position:relative}.eds-c-header__nav-container{align-items:center;display:flex;flex-wrap:wrap;margin:0 auto 4px;max-width:1280px;padding:0 8px;position:relative}.eds-c-header__nav-container>:not(:last-child){margin-right:32px}.eds-c-header__link-container{align-items:center;display:flex;flex:1 0 auto;gap:8px 16px;justify-content:space-between}.eds-c-header__list{list-style:none;margin:0;padding:0}.eds-c-header__list-item{font-weight:700;margin:0 auto;max-width:1280px;padding:8px}.eds-c-header__list-item:not(:last-child){border-bottom:2px solid #c5e0f4}.eds-c-header__item{color:inherit}@media only screen and (min-width:768px){.eds-c-header__item--menu{display:none;visibility:hidden}.eds-c-header__item--menu:first-child+*{margin-block-start:0}}.eds-c-header__item--inline-links{display:none;visibility:hidden}@media only screen and (min-width:768px){.eds-c-header__item--inline-links{display:flex;gap:16px 16px;visibility:visible}}.eds-c-header__item--divider:before{border-left:2px solid #c5e0f4;content:"";height:calc(100% - 16px);margin-left:-15px;position:absolute;top:8px}.eds-c-header__brand{padding:16px 8px}.eds-c-header__brand a{display:block;line-height:1;text-decoration:none}.eds-c-header__brand img{height:1.5rem;width:auto}.eds-c-header__link{color:inherit;display:inline-block;font-weight:700;padding:16px 8px;position:relative;text-decoration-color:transparent;white-space:nowrap;word-break:normal}.eds-c-header__icon{fill:currentcolor;display:inline-block;font-size:1.5rem;height:1em;transform:translate(0);vertical-align:bottom;width:1em}.eds-c-header__icon+*{margin-left:8px}.eds-c-header__expander{background-color:#f0f7fc}.eds-c-header__search{display:block;padding:24px 0}@media only screen and (min-width:768px){.eds-c-header__search{max-width:70%}}.eds-c-header__search-container{position:relative}.eds-c-header__search-label{color:inherit;display:inline-block;font-weight:700;margin-bottom:8px}.eds-c-header__search-input{background-color:#fff;border:1px solid #000;padding:8px 48px 8px 8px;width:100%}.eds-c-header__search-button{background-color:transparent;border:0;color:inherit;height:100%;padding:0 8px;position:absolute;right:0}.has-tethered.eds-c-header__expander{border-bottom:2px solid #01324b;left:0;margin-top:-2px;top:100%;width:100%;z-index:10}@media only screen and (min-width:768px){.has-tethered.eds-c-header__expander--menu{display:none;visibility:hidden}}.has-tethered .eds-c-header__heading{display:none;visibility:hidden}.has-tethered .eds-c-header__heading:first-child+*{margin-block-start:0}.has-tethered .eds-c-header__search{margin:auto}.eds-c-header__heading{margin:0 auto;max-width:1280px;padding:16px 16px 0}.eds-c-pagination{align-items:center;display:flex;flex-wrap:wrap;font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;font-size:.875rem;gap:16px 0;justify-content:center;line-height:1.4;list-style:none;margin:0;padding:32px 0}@media only screen and (min-width:480px){.eds-c-pagination{padding:32px 16px}}.eds-c-pagination__item{margin-right:8px}.eds-c-pagination__item--prev{margin-right:16px}.eds-c-pagination__item--next .eds-c-pagination__link,.eds-c-pagination__item--prev .eds-c-pagination__link{padding:16px 8px}.eds-c-pagination__item--next{margin-left:8px}.eds-c-pagination__item:last-child{margin-right:0}.eds-c-pagination__link{align-items:center;color:#222;cursor:pointer;display:inline-block;font-size:1rem;margin:0;padding:16px 24px;position:relative;text-align:center;transition:all .2s ease 0s}.eds-c-pagination__link:visited{color:#222}.eds-c-pagination__link--disabled{border-color:#555;color:#555;cursor:default}.eds-c-pagination__link--active{background-color:#01324b;background-image:none;border-radius:8px;color:#fff}.eds-c-pagination__link--active:focus,.eds-c-pagination__link--active:hover,.eds-c-pagination__link--active:visited{color:#fff}.eds-c-pagination__link-container{align-items:center;display:flex}.eds-c-pagination__icon{fill:#222;height:1.5rem;width:1.5rem}.eds-c-pagination__icon--disabled{fill:#555}.eds-c-pagination__visually-hidden{border:0;clip:rect(0,0,0,0);clip-path:inset(50%);height:1px;overflow:hidden;padding:0;position:absolute!important;white-space:nowrap;width:1px}.c-breadcrumbs{color:#333;font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs>li{display:inline}svg.c-breadcrumbs__chevron{margin:0 .25rem;fill:#333;height:10px;width:10px}.c-breadcrumbs--contrast,.c-breadcrumbs--contrast .c-breadcrumbs__link{color:#fff}.c-breadcrumbs--contrast svg.c-breadcrumbs__chevron{fill:#fff}@media only screen and (max-width:479px){.c-breadcrumbs .c-breadcrumbs__item{display:none}.c-breadcrumbs .c-breadcrumbs__item:last-child,.c-breadcrumbs .c-breadcrumbs__item:nth-last-child(2){display:inline}}.c-skip-link{background:#01324b;bottom:auto;color:#fff;font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;font-size:1rem;padding:8px;position:absolute;text-align:center;transform:translatey(-100%);width:100%;z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:active,.c-skip-link:hover,.c-skip-link:link,.c-skip-link:visited{color:#fff}.c-skip-link:focus{transform:translatey(0)}.l-with-sidebar{display:flex;flex-wrap:wrap}.l-with-sidebar>*{margin:0}.l-with-sidebar__sidebar{flex-basis:var(--with-sidebar--basis,400px);flex-grow:1}.l-with-sidebar>:not(.l-with-sidebar__sidebar){flex-basis:0px;flex-grow:999;min-width:var(--with-sidebar--min,53%)}.l-with-sidebar>:first-child{padding-right:4rem}@supports (gap:1em){.l-with-sidebar>:first-child{padding-right:0}.l-with-sidebar{gap:var(--with-sidebar--gap,4rem)}}.c-header__link{color:inherit;display:inline-block;font-weight:700;padding:16px 8px;position:relative;text-decoration-color:transparent;white-space:nowrap;word-break:normal}.app-masthead__colour-4{--background-color:#ff9500;--gradient-light:rgba(0,0,0,.5);--gradient-dark:rgba(0,0,0,.8)}.app-masthead{background:var(--background-color,#0070a8);position:relative}.app-masthead:after{background:radial-gradient(circle at top right,var(--gradient-light,rgba(0,0,0,.4)),var(--gradient-dark,rgba(0,0,0,.7)));bottom:0;content:"";left:0;position:absolute;right:0;top:0}@media only screen and (max-width:479px){.app-masthead:after{background:linear-gradient(225deg,var(--gradient-light,rgba(0,0,0,.4)),var(--gradient-dark,rgba(0,0,0,.7)))}}.app-masthead__container{color:var(--masthead-color,#fff);margin:0 auto;max-width:1280px;padding:0 16px;position:relative;z-index:1}.u-clear-both{clear:both}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-justify-content-space-between{justify-content:space-between}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-visually-hidden{border:0;clip:rect(0,0,0,0);clip-path:inset(50%);height:1px;overflow:hidden;padding:0;position:absolute!important;white-space:nowrap;width:1px}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-ma-16{margin:16px}.u-mt-0{margin-top:0}.u-mt-24{margin-top:24px}.u-mt-32{margin-top:32px}.u-mb-8{margin-bottom:8px}.u-mb-32{margin-bottom:32px}.u-sans-serif{font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif}.u-serif{font-family:merriweather,serif}h1,h2,h3{-webkit-font-smoothing:antialiased}p{overflow-wrap:break-word;word-break:break-word}.u-h4{font-size:1.25rem;font-weight:700;line-height:1.2}.u-mbs-0{margin-block-start:0!important}.c-article-header{font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;padding:0}.c-article-identifiers__item{list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{margin-right:0;padding-right:0}@media only screen and (min-width:876px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:767px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#025e8d;border-color:transparent;color:#fff}.c-article-body .c-article-access-provider{padding:8px 16px}.c-article-body .c-article-access-provider,.c-notes{border:1px solid #d5d5d5;border-image:initial;border-left:none;border-right:none;margin:24px 0}.c-article-body .c-article-access-provider__text{color:#555}.c-article-body .c-article-access-provider__text,.c-notes__text{font-size:1rem;margin-bottom:0;padding-bottom:2px;padding-top:2px;text-align:center}.c-article-body .c-article-author-affiliation__address{color:inherit;font-weight:700;margin:0}.c-article-body .c-article-author-affiliation__authors-list{list-style:none;margin:0;padding:0}.c-article-body .c-article-author-affiliation__authors-item{display:inline;margin-left:0}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-article-body .c-article-subject-list--no-mb{margin-bottom:0}.c-code-block{border:1px solid #fff;font-family:monospace;margin:0 0 24px;padding:20px}.c-code-block__heading{font-weight:400;margin-bottom:16px}.c-code-block__line{display:block;overflow-wrap:break-word;white-space:pre-wrap}.c-article-share-box{font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;margin-bottom:24px}.c-article-share-box__description{font-size:1rem;margin-bottom:8px}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__additional-info{color:#626262;font-size:.813rem}.c-article-share-box__button{background:#fff;box-sizing:content-box;text-align:center}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#025e8d;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{font-size:1rem}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;font-size:1.25rem;font-weight:700;line-height:1.2;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{align-items:center;display:flex}.c-article-section__figure-caption{display:block;margin-bottom:8px;word-break:break-word}.c-article-section__figure .video,p.app-article-masthead__access--above-download{margin:0 0 16px}.c-cod{display:block;font-size:1rem;width:100%}.c-cod__form{background:#ebf0f3}.c-cod__prompt{font-size:1.125rem;line-height:1.3;margin:0 0 24px}.c-cod__label{display:block;margin:0 0 4px}.c-cod__row{display:flex;margin:0 0 16px}.c-cod__row:last-child{margin:0}.c-cod__input{border:1px solid #d5d5d5;border-radius:2px;flex-shrink:0;margin:0;padding:13px}.c-cod__input--submit{background-color:#025e8d;border:1px solid #025e8d;color:#fff;flex-shrink:1;margin-left:8px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-cod__input--submit-single{flex-basis:100%;flex-shrink:0;margin:0}.c-cod__input--submit:focus,.c-cod__input--submit:hover{background-color:#fff;color:#025e8d}.save-data .c-article-author-institutional-author__sub-division,.save-data .c-article-equation__number,.save-data .c-article-figure-description,.save-data .c-article-fullwidth-content,.save-data .c-article-main-column,.save-data .c-article-satellite-article-link,.save-data .c-article-satellite-subtitle,.save-data .c-article-table-container,.save-data .c-blockquote__body,.save-data .c-code-block__heading,.save-data .c-reading-companion__figure-title,.save-data .c-reading-companion__reference-citation,.save-data .c-site-messages--nature-briefing-email-variant .serif,.save-data .c-site-messages--nature-briefing-email-variant.serif,.save-data .serif,.save-data .u-serif,.save-data h1,.save-data h2,.save-data h3{font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif}.c-pdf-download__link{display:flex;flex:1 1 0%;padding:13px 24px}.c-pdf-download__link:hover{text-decoration:none}@media only screen and (min-width:768px){.c-context-bar--sticky .c-pdf-download__link{align-items:center;flex:1 1 183px}}@media only screen and (max-width:320px){.c-context-bar--sticky .c-pdf-download__link{padding:16px}}.c-article-body .c-article-recommendations-list,.c-book-body .c-article-recommendations-list{display:flex;flex-direction:row;gap:16px 16px;margin:0;max-width:100%;padding:16px 0 0}.c-article-body .c-article-recommendations-list__item,.c-book-body .c-article-recommendations-list__item{flex:1 1 0%}@media only screen and (max-width:767px){.c-article-body .c-article-recommendations-list,.c-book-body .c-article-recommendations-list{flex-direction:column}}.c-article-body .c-article-recommendations-card__authors{display:none;font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;font-size:.875rem;line-height:1.5;margin:0 0 8px}@media only screen and (max-width:767px){.c-article-body .c-article-recommendations-card__authors{display:block;margin:0}}.c-article-body .c-article-history{margin-top:24px}.app-article-metrics-bar p{margin:0}.app-article-masthead{display:flex;flex-direction:column;gap:16px 16px;padding:16px 0 24px}.app-article-masthead__info{display:flex;flex-direction:column;flex-grow:1}.app-article-masthead__brand{border-top:1px solid hsla(0,0%,100%,.8);display:flex;flex-direction:column;flex-shrink:0;gap:8px 8px;min-height:96px;padding:16px 0 0}.app-article-masthead__brand img{border:1px solid #fff;border-radius:8px;box-shadow:0 4px 15px 0 hsla(0,0%,50%,.25);height:auto;left:0;position:absolute;width:72px}.app-article-masthead__journal-link{display:block;font-size:1.125rem;font-weight:700;margin:0 0 8px;max-width:400px;padding:0 0 0 88px;position:relative}.app-article-masthead__journal-title{display:-webkit-box;overflow:hidden;-webkit-box-orient:vertical;-webkit-line-clamp:3}.app-article-masthead__submission-link{align-items:center;display:flex;font-size:1rem;gap:4px 4px;margin:0 0 0 88px}.app-article-masthead__access{align-items:center;display:flex;flex-wrap:wrap;font-size:.875rem;font-weight:300;gap:4px 4px;margin:0}.app-article-masthead__buttons{display:flex;flex-flow:column wrap;gap:16px 16px}.app-article-masthead__access svg{fill:currentcolor}.app-article-masthead a{color:#fff}.app-article-masthead a.c-pdf-download__link,.app-article-masthead__syndicated-card a,.app-article-masthead__syndicated-card a:visited,.app-masthead--pastel .app-article-masthead a,.app-masthead--pastel .app-article-masthead a:visited{color:#000}.app-masthead--pastel .c-pdf-download a.u-button--primary,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--primary{background-color:#025e8d;border:2px solid transparent;box-shadow:none;color:#fff;font-weight:700}.app-masthead--pastel .c-pdf-download a.u-button--primary:focus,.app-masthead--pastel .c-pdf-download a.u-button--primary:hover,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--primary:focus,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--primary:hover{background:0 0;border:2px solid #025e8d;box-shadow:none;color:#025e8d}.app-masthead--pastel .c-pdf-download a.u-button--secondary,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--secondary{background:0 0;border:2px solid #025e8d;color:#025e8d}.app-masthead--pastel .c-pdf-download a.u-button--secondary:focus,.app-masthead--pastel .c-pdf-download a.u-button--secondary:hover,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--secondary:focus,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--secondary:hover{background-color:#025e8d;border:2px solid transparent;color:#fff}@media only screen and (min-width:768px){.app-article-masthead{flex-direction:row;gap:64px 64px;padding:24px 0}.app-article-masthead__brand{border:0;padding:0}.app-article-masthead__brand img{height:auto;position:static;width:auto}.app-article-masthead__buttons{align-items:center;flex-direction:row;margin-top:auto}.app-article-masthead__journal-link{display:flex;flex-direction:column;gap:24px 24px;margin:0 0 8px;padding:0}.app-article-masthead__submission-link{margin:0}}@media only screen and (min-width:1024px){.app-article-masthead__brand{flex-basis:400px}}.app-article-masthead .c-article-identifiers{font-size:.875rem;font-weight:300;line-height:1;margin:0 0 8px;overflow:hidden;padding:0}.app-article-masthead .c-article-identifiers--cite-list{margin:0 0 16px}.app-article-masthead .c-article-identifiers *{color:#fff}.app-article-masthead .c-cod{display:none}.app-article-masthead .c-article-identifiers__item{border-left:1px solid #fff;border-right:0;margin:0 17px 8px -9px;padding:0 0 0 8px}.app-article-masthead .c-article-identifiers__item--cite{border-left:0}.app-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;padding:16px 0 0;row-gap:24px}.app-article-metrics-bar__item{padding:0 16px 0 0}.app-article-metrics-bar__count{font-weight:700}.app-article-metrics-bar__label{font-weight:400;padding-left:4px}.app-article-metrics-bar__icon{height:auto;margin-right:4px;margin-top:-4px;width:auto}.app-article-metrics-bar__arrow-icon{margin:4px 0 0 4px}.app-article-metrics-bar a{color:#000}.app-article-metrics-bar .app-article-metrics-bar__item--metrics{padding-right:0}.app-overview-section .c-article-author-list,.app-overview-section__authors{line-height:2}.app-article-metrics-bar{margin-top:8px}.c-book-toc-pagination+.c-book-section__back-to-top{margin-top:0}.c-article-body .c-article-access-provider__text--chapter{color:#222;font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;padding:20px 0}.c-article-body .c-article-access-provider__text--chapter svg.c-status-message__icon{fill:#003f8d;vertical-align:middle}.c-article-body-section__content--separator{padding-top:40px}.c-pdf-download__link{max-height:44px}.app-article-access .u-button--primary,.app-article-access .u-button--primary:visited{color:#fff}.c-article-authors-search__list{align-items:center;display:flex;flex-wrap:wrap;gap:16px 16px;justify-content:center}@media only screen and (min-width:480px){.c-article-authors-search__list{justify-content:normal}}.c-article-authors-search__text{align-items:center;display:flex;flex-flow:column wrap;font-size:14px;justify-content:center}@media only screen and (min-width:480px){.c-article-authors-search__text{flex-direction:row;font-size:16px}}.c-article-authors-search__links-text{font-weight:700;margin-right:8px;text-align:center}@media only screen and (min-width:480px){.c-article-authors-search__links-text{text-align:left}}.c-article-authors-search__list-item--left{flex:1 1 100%}@media only screen and (min-width:480px){.c-article-authors-search__list-item--left{flex-basis:auto}}.c-article-authors-search__list-item--right{flex:1 1 auto}.c-article-identifiers{margin:0}.c-article-identifiers__item{border-right:2px solid #cedbe0;color:#222;font-size:14px}@media only screen and (min-width:480px){.c-article-identifiers__item{font-size:16px}}.c-article-identifiers__item:last-child{border-right:none}.c-article-authors-search__cta-link{font-size:14px}@media only screen and (min-width:480px){.c-article-authors-search__cta-link{font-size:16px}}.c-article-sidebar{display:none}@media only screen and (min-width:1024px){.c-article-sidebar{display:block}}.c-cod__form{border-radius:12px}.c-cod__label{font-size:.875rem}.c-cod .c-status-message{align-items:center;justify-content:center;margin-bottom:16px;padding-bottom:16px}@media only screen and (min-width:1024px){.c-cod .c-status-message{align-items:inherit}}.c-cod .c-status-message__icon{margin-top:4px}.c-cod .c-cod__prompt{font-size:1rem;margin-bottom:16px}.c-spp-access-message .c-status-message__icon{color:#00a69d;margin-top:8px}.c-article-body .app-article-access,.c-book-body .app-article-access{display:block}@media only screen and (min-width:1024px){.c-article-body .app-article-access,.c-book-body .app-article-access{display:none}}.c-article-body .app-card-service{margin-bottom:32px}@media only screen and (min-width:1024px){.c-article-body .app-card-service{display:none}}.app-article-access .buybox__buy .u-button--secondary,.app-article-access .u-button--primary,.c-cod__row .u-button--primary{background-color:#025e8d;border:2px solid #025e8d;box-shadow:none;font-size:1rem;font-weight:700;gap:8px 8px;justify-content:center;line-height:1.4;padding:8px 24px}.app-article-access .buybox__buy .u-button--secondary,.app-article-access .u-button--primary:hover,.c-cod__row .u-button--primary:hover{background-color:#fff;color:#025e8d}.app-article-access .buybox__buy .u-button--secondary:hover{background-color:#025e8d;color:#fff}.buybox__buy .c-notes__text{color:#666;font-size:.875rem;padding:0 16px 8px}.c-cod__input{flex-basis:auto;width:100%}.c-article-title{font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;font-size:2.25rem;font-weight:700;line-height:1.2;margin:12px 0}.c-reading-companion__figure-item figure{margin:0}@media only screen and (min-width:768px){.c-article-title{margin:16px 0}}.app-article-access{border:1px solid #cedbe0;border-radius:12px;margin:0 0 32px}.app-article-access__heading{border-bottom:1px solid #cedbe0;font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;font-size:1.125rem;font-weight:700;margin:0;padding:16px;text-align:center}.c-article-body .app-article-access p{margin-bottom:0}@media only screen and (min-width:1024px){.app-article-access{margin:0 0 24px}}.c-status-message{font-size:1rem}.c-article-body{font-size:1.125rem}.c-article-body dl,.c-article-body ol,.c-article-body p,.c-article-body ul{margin-bottom:32px;margin-top:0}.c-article-access-provider__text:last-of-type,.c-article-body .c-notes__text:last-of-type{margin-bottom:0}.c-article-body ol p,.c-article-body ul p{margin-bottom:16px}.c-article-section__figure-caption{font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif}.c-reading-companion__figure-item{border-top-color:#cedbe0}.c-reading-companion__sticky{max-width:400px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;padding:16px 0}.c-reading-companion__reference-item:first-child{padding-top:0}.c-article-share-box__button,.js .c-article-authors-search__item .c-article-button{background:0 0;border:2px solid #025e8d;border-radius:32px;box-shadow:none;color:#025e8d;font-size:1rem;font-weight:700;line-height:1.4;margin:0;padding:8px 24px;transition:all .2s ease 0s}.c-article-authors-search__item .c-article-button{width:100%}.c-pdf-download .c-pdf-download__link{align-items:center;background-color:#fff;border:2px solid #fff;border-radius:32px;box-shadow:none;color:#01324b;cursor:pointer;font-family:merriweather sans,helvetica neue,helvetica,arial,sans-serif;font-size:1rem;font-weight:700;justify-content:center;line-height:1.4;padding:8px 24px;text-decoration:none}.c-context-bar__container .c-pdf-download .c-pdf-download__link{background-color:#025e8d;background-image:none;border:2px solid #025e8d;box-shadow:none;color:#fff;font-size:1rem;font-weight:700;line-height:1.4;padding:8px 24px}.c-pdf-download .c-pdf-download__link:hover{background:0 0;border:2px solid #fff;box-shadow:none;color:#fff}.c-pdf-download .c-pdf-download__link:focus{background:0 0;box-shadow:none;color:#fff}.c-context-bar__container .c-pdf-download .c-pdf-download__link:hover{border:2px solid #025e8d;box-shadow:none;color:#025e8d}.c-context-bar__container .c-pdf-download .c-pdf-download__link:focus,.c-pdf-download .c-pdf-download__link:focus{border:2px solid #025e8d}.c-article-share-box__button:focus:focus,.c-article__pill-button:focus:focus,.c-context-bar__container .c-pdf-download .c-pdf-download__link:focus:focus,.c-pdf-download .c-pdf-download__link:focus:focus{outline:3px solid #08c;will-change:transform}.c-pdf-download__link .u-icon{padding-top:0}.c-bibliographic-information__column button{margin-bottom:16px}.c-article-body .c-article-author-affiliation__list p,.c-article-body .c-article-author-information__list p,figure{margin:0}.c-article-share-box__button{margin-right:16px}.c-status-message--boxed{border-radius:12px}.c-article-associated-content__collection-title{font-size:1rem}.app-card-service__description,.c-article-body .app-card-service__description{color:#222;margin-bottom:0;margin-top:8px}.app-article-access__subscriptions a,.app-article-access__subscriptions a:visited,.app-book-series-listing__item a,.app-book-series-listing__item a:hover,.app-book-series-listing__item a:visited,.c-article-author-list a,.c-article-author-list a:visited,.c-article-buy-box a,.c-article-buy-box a:visited,.c-article-peer-review a,.c-article-peer-review a:visited,.c-article-satellite-subtitle a,.c-article-satellite-subtitle a:visited,.c-breadcrumbs__link,.c-breadcrumbs__link:hover,.c-breadcrumbs__link:visited{color:#000}.c-article-author-list svg{height:24px;margin:0 0 0 6px;width:24px}.c-article-header{margin-bottom:32px}@media only screen and (min-width:876px){.js .c-ad--conditional{display:block}}.u-lazy-ad-wrapper{background-color:#fff;display:none;min-height:149px}@media only screen and (min-width:876px){.u-lazy-ad-wrapper{display:block}}p.c-ad__label{margin-bottom:4px}.c-ad--728x90{background-color:#fff;border-bottom:2px solid #cedbe0} } @media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) { .eds-c-header__brand img{height:24px;width:203px}.app-article-masthead__journal-link img{height:93px;width:72px}@media only screen and (min-width:769px){.app-article-masthead__journal-link img{height:161px;width:122px}} } config = { env: 'live', site: '213.springer.com', sitewithpath: '213.springer.com' + window.location.pathname, twitterhashtag: '213', cmsprefix: 'https://studio-cms.springernature.com/studio/', publisherbrand: 'springer', mustardcut: false }; window.datalayer = [{"ga key":"ua-26408784-1","doi":"10.1007/s00213-024-06686-7","page":"article","springerjournal":true,"publishing model":"hybrid access","country":"us","japan":false,"doi":"10.1007-s00213-024-06686-7","journal id":213,"journal title":"psychopharmacology","imprint":"springer","keywords":"attention deficit hyperactivity disorder, vesicular monoamine transporter, neurodevelopmental disorder, amphetamines, methylphenidate, omega-3 fatty acids, bupropion, norepinephrine, dopamine, ph gradient model","kwrd":["attention_deficit_hyperactivity_disorder","vesicular_monoamine_transporter","neurodevelopmental_disorder","amphetamines","methylphenidate","omega-3_fatty_acids","bupropion","norepinephrine","dopamine","ph_gradient_model"],"labs":"y","ksg":"krux.segments","kuid":"krux.uid","has body":"y","features":[],"open access":"n","hasaccess":"n","bypasspaywall":"n","user":{"license":{"businesspartnerid":[],"businesspartneridstring":""}},"access type":"no-access","bpids":"","bpnames":"","bpid":["1"],"vg wort identifier":"pw-vgzm.415900-10.1007-s00213-024-06686-7","full html":"n","subject codes":["scb","scb18006","scb21007","sch53003"],"pmc":["b","b18006","b21007","h53003"],"session":{"authentication":{"loginstatus":"n"},"attributes":{"edition":"academic"}},"entitlement":{"accessdecision":"noaccess","requireauthentication":false},"content":{"serial":{"eissn":"1432-2072","pissn":"0033-3158"},"type":"article","category":{"pmc":{"primarysubject":"biomedicine","primarysubjectcode":"b","secondarysubjects":{"1":"neurosciences","2":"pharmacology/toxicology","3":"psychiatry"},"secondarysubjectcodes":{"1":"b18006","2":"b21007","3":"h53003"}},"sucode":"sc3","articletype":"review","snt":["attention deficit disorder","transport vesicle","adhd","transporters in the nervous system","neuropharmacology","drug therapy"]},"attributes":{"deliveryplatform":"oscar"}},"page":{"attributes":{"environment":"live"},"category":{"pagetype":"article"}},"event category":"article"}]; window.datalayer = window.datalayer || []; window.datalayer.push({ ga4measurementid: 'g-b3e4ql2tpr', ga360trackingid: 'ua-26408784-1', twitterid: 'o47a7', baiduid: 'aef3043f025ccf2305af8a194652d70b', ga4serverurl: 'https://collect.springer.com', imprint: 'springerlink', page: { attributes:{ featureflags: [ { name: 'darwin-orion', active: true }, { name: 'show-profile-page-links', active: true }, ], darwinavailable: true } } }); (function(w, d) { w.config = w.config || {}; w.config.mustardcut = false; if (w.matchmedia && w.matchmedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) { w.config.mustardcut = true; d.classlist.add('js'); d.classlist.remove('grade-c'); d.classlist.remove('no-js'); } })(window, document.documentelement); if (window.config.mustardcut) { (function(w, d) { window.component = {}; window.suppresssharebutton = false; window.onarticlepage = true; var currentscript = d.currentscript || d.head.queryselector('script.js-entry'); function catchnomodulesupport() { var scriptel = d.createelement('script'); return (!('nomodule' in scriptel) && 'onbeforeload' in scriptel) } var headscripts = [ {'src': '/oscar-static/js/polyfill-es5-bundle-b4356fa7f5.js', 'async': false} ]; var bodyscripts = [ {'src': '/oscar-static/js/global-article-es5-bundle-c7bdbee6e7.js', 'async': false, 'module': false}, {'src': '/oscar-static/js/global-article-es6-bundle-8cfe1d6fdf.js', 'async': false, 'module': true} ]; function createscript(script) { var scriptel = d.createelement('script'); scriptel.src = script.src; scriptel.async = script.async; if (script.module === true) { scriptel.type = "module"; if (catchnomodulesupport()) { scriptel.src = ''; } } else if (script.module === false) { scriptel.setattribute('nomodule', true) } if (script.charset) { scriptel.setattribute('charset', script.charset); } return scriptel; } for (var i = 0; i window.initgtm = function() { if (window.config.mustardcut) { (function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({'gtm.start': new date().gettime(), event: 'gtm.js'}); var f = d.getelementsbytagname(s)[0], j = d.createelement(s), dl = l != 'datalayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://sgtm.springer.com/gtm.js?id=' + i + dl; f.parentnode.insertbefore(j, f); performance.mark('sn gpt ads gtm-container-fired'); })(window, document, 'script', 'datalayer', 'gtm-mrvxshq'); } } (function (w, d, t) { function cc() { var h = w.location.hostname; var e = d.createelement(t), s = d.getelementsbytagname(t)[0]; if (h.indexof('springer.com') > -1 && h.indexof('biomedcentral.com') === -1 && h.indexof('springeropen.com') === -1) { e.src = 'https://cmp.springer.com/production_live/en/consent-bundle-17-70.js'; e.setattribute('onload', "initgtm(window,document,'script','datalayer','gtm-mrvxshq')"); } else if (h.indexof('biomedcentral.com') > -1) { e.src = 'https://cmp.biomedcentral.com/production_live/en/consent-bundle-15-45.js'; e.setattribute('onload', "initgtm(window,document,'script','datalayer','gtm-mrvxshq')"); } else if (h.indexof('springeropen.com') > -1) { e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-16-40.js'; e.setattribute('onload', "initgtm(window,document,'script','datalayer','gtm-mrvxshq')"); } else if (h.indexof('springernature.com') > -1) { e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-49-43.js'; e.setattribute('onload', "initgtm(window,document,'script','datalayer','gtm-nk22kls')"); } else { e.src = '/oscar-static/js/cookie-consent-es5-bundle-8d962b73c2.js'; e.setattribute('data-consent', h); } s.insertadjacentelement('afterend', e); } cc(); })(window, document, 'script'); {"mainentity":{"headline":"role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review","description":"the diagnostic and statistical manual of mental disorders (fifth edition) classifies attention deficit hyperactivity disorder (adhd) as a neurodevelopmental disorder that interferes with human functioning and development. as the clinical presentation of adhd involves a deficiency in executive function, neurocognitive deficits involving distinctive neuropathological changes must be present for clinical diagnosis. the vesicular monoamine transporter (vmat), specifically vmat-2, plays a role in adhd pathogenesis. in addition, experimental data show that the stimulants (amphetamines and methylphenidate) are first-line treatments for the condition because of their extensive interaction with vmat-2. the interactions of peptides, bupropion, and nutritional supplements with vmat-2 receptors have been researched, but more evidence is needed to elucidate their pharmacodynamic properties. therefore, this literature review evaluated the current pharmacological treatment modalities, peptides, and nutritional supplements for adhd that target the vmat-2 system. we obtained relevant studies from several platforms, including the national center for biotechnology, clinical key, access medicine, and pubmed. from the results of these studies, we observed that stimulants interact highly with the vmat-2 transporter, with omega-3 fatty acids, peptides, and bupropion exerting some modulatory activity on vmat-2. these agents should be considered for the future treatment of adhd, although clinical-level research involving human participants is necessary.","datepublished":"2024-09-20t00:00:00z","datemodified":"2024-09-20t00:00:00z","pagestart":"2191","pageend":"2203","sameas":"https://doi.org/10.1007/s00213-024-06686-7","keywords":["attention deficit hyperactivity disorder","vesicular monoamine transporter","neurodevelopmental disorder","amphetamines","methylphenidate","omega-3 fatty acids","bupropion","norepinephrine","dopamine","ph gradient model","neurosciences","pharmacology/toxicology","psychiatry"],"image":["https://media.springernature.com/lw1200/springer-static/image/art%3a10.1007%2fs00213-024-06686-7/mediaobjects/213_2024_6686_figb_html.png","https://media.springernature.com/lw1200/springer-static/image/art%3a10.1007%2fs00213-024-06686-7/mediaobjects/213_2024_6686_figa_html.png"],"ispartof":{"name":"psychopharmacology","issn":["1432-2072","0033-3158"],"volumenumber":"241","@type":["periodical","publicationvolume"]},"publisher":{"name":"springer berlin heidelberg","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"imageobject"},"@type":"organization"},"author":[{"name":"halford warlick iv","url":"http://orcid.org/0000-0003-1643-2011","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"email":"halfordwarlick@yahoo.com","@type":"person"},{"name":"darcy tocci","affiliation":[{"name":"health profession division, nova southeastern university, fort lauderdale","address":{"name":"dr. kiran c. patel college of allopathic medicine, health profession division, nova southeastern university, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"sukriti prashar","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"erick boldt","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"alena khalil","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"simran arora","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"thomas matthews","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"talha wahid","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"richard fernandez","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"dhiya ram","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"lexie leon","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"arisha arain","affiliation":[{"name":"halmos college of arts and sciences, nova southeastern university, fort lauderdale","address":{"name":"halmos college of arts and sciences, nova southeastern university, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"jose rey","affiliation":[{"name":" health profession division, nova southeastern university, fort lauderdale","address":{"name":"college of pharmacy, health profession division, nova southeastern university, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"kelley davis","affiliation":[{"name":"health profession division, nova southeastern university, fort lauderdale","address":{"name":"dr. kiran c. patel college of allopathic medicine, health profession division, nova southeastern university, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"}],"isaccessibleforfree":false,"haspart":{"isaccessibleforfree":false,"cssselector":".main-content","@type":"webpageelement"},"@type":"scholarlyarticle"},"@context":"https://schema.org","@type":"webpage"} skip to main content advertisement window.sn = window.sn || {}; window.sn.libs = window.sn.libs || {}; window.sn.libs.ads = window.sn.libs.ads || {}; window.sn.libs.ads.slotconfig = window.sn.libs.ads.slotconfig || {}; window.sn.libs.ads.slotconfig['lb1'] = { 'pos': 'top', 'type': 'top', }; window.sn.libs.ads.slotconfig['unitpath'] = '/270604982/springerlink/213/article'; log in menu find a journal publish with us track your research search cart (function () { var exports = {}; if (window.fetch) { "use strict"; object.defineproperty(exports, "__esmodule", { value: true }); exports.headerwidgetclientinit = void 0; var headerwidgetclientinit = function (getcartinfo) { document.body.addeventlistener("updatedcart", function () { updatecarticon(); }, false); return updatecarticon(); function updatecarticon() { return getcartinfo() .then(function (res) { return res.json(); }) .then(refreshcartstate) .catch(function (_) { }); } function refreshcartstate(json) { var indicator = document.queryselector("#ecommerce-header-cart-icon-link .cart-info"); /* istanbul ignore else */ if (indicator && json.itemcount) { indicator.style.display = 'block'; indicator.textcontent = json.itemcount > 9 ? '9+' : json.itemcount.tostring(); var morethanoneitem = json.itemcount > 1; indicator.setattribute('title', "there ".concat(morethanoneitem ? "are" : "is", " ").concat(json.itemcount, " item").concat(morethanoneitem ? "s" : "", " in your cart")); } return json; } }; exports.headerwidgetclientinit = headerwidgetclientinit; headerwidgetclientinit( function () { return window.fetch("https://cart.springer.com/cart-info", { credentials: "include", headers: { accept: "application/json" } }) } ) }})() home psychopharmacology article role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review review published: 20 september 2024 volume 241 , pages 2191–2203, ( 2024 ) cite this article psychopharmacology aims and scope submit manuscript halford warlick iv orcid: orcid.org/0000-0003-1643-2011 1 , darcy tocci 2 , sukriti prashar 1 , erick boldt 1 , alena khalil 1 , simran arora 1 , thomas matthews 1 , talha wahid 1 , richard fernandez 1 , dhiya ram 1 , lexie leon 1 , arisha arain 4 , jose rey 3 &amp; … kelley davis 2 show authors 1062 accesses 6 altmetric explore all metrics abstract rationale the diagnostic and statistical manual of mental disorders (fifth edition) classifies attention deficit hyperactivity disorder (adhd) as a neurodevelopmental disorder that interferes with human functioning and development. as the clinical presentation of adhd involves a deficiency in executive function, neurocognitive deficits involving distinctive neuropathological changes must be present for clinical diagnosis. objectives the vesicular monoamine transporter (vmat), specifically vmat-2, plays a role in adhd pathogenesis. in addition, experimental data show that the stimulants (amphetamines and methylphenidate) are first-line treatments for the condition because of their extensive interaction with vmat-2. the interactions of peptides, bupropion, and nutritional supplements with vmat-2 receptors have been researched, but more evidence is needed to elucidate their pharmacodynamic properties. therefore, this literature review evaluated the current pharmacological treatment modalities, peptides, and nutritional supplements for adhd that target the vmat-2 system. methods, results, and conclusions we obtained relevant studies from several platforms, including the national center for biotechnology, clinical key, access medicine, and pubmed. from the results of these studies, we observed that stimulants interact highly with the vmat-2 transporter, with omega-3 fatty acids, peptides, and bupropion exerting some modulatory activity on vmat-2. these agents should be considered for the future treatment of adhd, although clinical-level research involving human participants is necessary. this is a preview of subscription content, log in via an institution to check access. access this article log in via an institution subscribe and save springer+ from $39.99 /month starting from 10 chapters or articles per month access and download chapters and articles from more than 300k books and 2,500 journals cancel anytime view plans buy now buy article pdf usd 39.95 price excludes vat (usa) tax calculation will be finalised during checkout. instant access to the full article pdf. datalayer.push({"ecommerce":{"currency":"usd","impressions":[{"name":"role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review","id":"1432-2072","price":39.95,"brand":"springer berlin heidelberg","category":"neuroscience","variant":"ppv-article","quantity":1}]}}); ;(function () { if (window.localstorage) { window.localstorage.removeitem("springerplusrollout") } })() .springer-plus .buying-option-usps > li::before { background-image: url("data:image/svg+xml,%3csvg viewbox='0 0 100 100' xmlns='http://www.w3.org/2000/svg' fill='%230070a8'%3e%3ccircle cx='50' cy='50' r='50'/%3e%3c/svg%3e"); } institutional subscriptions .sprcom-buybox-articledarwin .buybox__access-option{ border-top: 1px solid #cedbe0; font-size: 1rem; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus{ background-color: #ebf6ff; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus-headline{ display: flex; justify-content: space-between; } .sprcom-buybox-articledarwin .springer-plus-heading{ border-bottom: 1px solid #c5e0f4; border-top: 1px solid #c5e0f4; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; font-size: 1.125rem; font-weight: 700; margin: 0; padding: 16px; text-align: center; } .sprcom-buybox-articledarwin .springer-plus-title{ align-items: center; display: flex; } .sprcom-buybox-articledarwin .springer-plus-title span{ margin-left: 8px; } .sprcom-buybox-articledarwin .springer-plus a{ background-color: #fff; border: 1px solid #025e8d; color: #025e8d; font-size: 16px; font-weight: 700; max-height: 44px; } .sprcom-buybox-articledarwin .springer-plus a span{ margin-right: 8px; } .sprcom-buybox-articledarwin .springer-plus a:hover{ background-color: #025e8d; border: 4px solid #025e8d; box-shadow: none; color: #fff; font-weight: 700; } .sprcom-buybox-articledarwin .springer-plus a:visited{ color: #025e8d; } .sprcom-buybox-articledarwin .springer-plus a:visited:hover{ color: #fff; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps{ color: #555; font-size: 1rem; line-height: 1.6; list-style: none; margin: 0; padding: 16px 0 24px 0; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li{ padding-left: 26px; position: relative; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li::before{ content: ''; height: 10px; left: 0; position: absolute; top: calc(0.8em - 5px); width: 10px; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li:not(:first-child){ margin-top: 4px; } fig. 1 fig. 2 similar content being viewed by others mechanisms of neurotransmitter transport and drug inhibition in human vmat2 article 01 november 2023 transport and inhibition mechanism for vmat2-mediated synaptic vesicle loading of monoamines article open access 02 january 2024 drug inhibition and substrate transport mechanisms of human vmat2 article open access 02 january 2025 window.datalayer = window.datalayer || []; window.datalayer.push({ recommendations: { recommender: 'semantic', model: 'specter', policy_id: 'na', timestamp: 1761044444, embedded_user: 'null' } }); explore related subjects discover the latest articles, books and news in related subjects, suggested using machine learning. adhd attention deficit disorder drug therapy neuropharmacology transporters in the nervous system transport vesicle references adler la, dirks b, deas pf, raychaudhuri a, dauphin mr, lasser ra, weisler rh (2013) lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. j clin psychiatry 74:694–702. https://doi.org/10.4088/jcp.12m08144 article cas pubmed google scholar alwindi m, bizanti a (2023) vesicular monoamine transporter (vmat) regional expression and roles in pathological conditions. heliyon 9:e22413. https://doi.org/10.1016/j.heliyon.2023.e22413 article cas pubmed pubmed central google scholar barlow rb, johnson o (1989) relations between structure and nicotine-like activity: x-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds. br j pharmacol 98:799–808. https://doi.org/10.1111/j.1476-5381.1989.tb14608.x article cas pubmed pubmed central google scholar barragán e, breuer d, döpfner m (2017) efficacy and safety of omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with adhd. j atten disord 21:433–441. https://doi.org/10.1177/1087054713518239 article pubmed google scholar biederman j, fried r, hammerness p, surman c, mehler b, petty cr, faraone sv, miller c, bourgeois m, meller b, godfrey km, reimer b (2012) the effects of lisdexamfetamine dimesylate on the driving performance of young adults with adhd: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. j psychiatr res 46:484–491. https://doi.org/10.1016/j.jpsychires.2012.01.007 article pubmed google scholar blick ska, keating gm (2007) lisdexamfetamine. paediatr drugs 9:129–135 discussion 136. https://doi.org/10.2165/00148581-200709020-00007 article pubmed google scholar blum k, chen alc, braverman er, comings de, chen tjh, arcuri v, blum sh, downs bw, waite rl, notaro a, lubar j, williams l, prihoda tj, palomo t, oscar-berman m (2008) attention-deficit-hyperactivity disorder and reward deficiency syndrome. neuropsychiatr dis treat 4:893–918. https://doi.org/10.2147/ndt.s2627 article pubmed pubmed central google scholar bristot g, ascoli bm, scotton e, géa lp, pfaffenseller b, kauer-sant’anna m (2019) effects of lithium on inflammatory and neurotrophic factors after an immune challenge in a lisdexamfetamine animal model of mania. braz j psychiatry 41:419–427. https://doi.org/10.1590/1516-4446-2017-0001 article pubmed pubmed central google scholar burns c, kidron a (eds) (2022) biochemistry, tyramine. statpearls. internet. in: statpearls publishing, treasure island (fl), p 2024 jan-. https://www.ncbi.nlm.nih.gov/books/nbk563197/ comiran e, kessler fh, fröehlich pe, limberger rp (2016) lisdexamfetamine: a pharmacokinetic review. eur j pharm sci 89:172–179. https://doi.org/10.1016/j.ejps.2016.04.026 article cas pubmed google scholar crooks pa, zheng g, vartak ap, culver jp, zheng f, horton db, dwoskin lp (2011) design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse. curr top med chem 11:1103–1127. https://doi.org/10.2174/156802611795371332 article cas pubmed pubmed central google scholar dhillon s, yang lph, curran mp (2008) bupropion: a review of its use in the management of major depressive disorder. drugs 68:653–689. https://doi.org/10.2165/00003495-200868050-00011 article cas pubmed google scholar di miceli m, derf a, gronier b (2022) consequences of acute or chronic methylphenidate exposure using ex vivo neurochemistry and in vivo electrophysiology in the prefrontal cortex and striatum of rats. int j mol sci 23:8588. https://doi.org/10.3390/ijms23158588 article cas pubmed pubmed central google scholar dupaul gj, weyandt ll, rossi js, vilardo ba, o’dell sm, carson km, verdi g, swentosky a (2012) double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with adhd. j atten disord 16:202–220. https://doi.org/10.1177/1087054711427299 article pubmed google scholar duvall mg, levy bd (2016) dha- and epa-derived resolvins, protectins, and maresins in airway inflammation. eur j pharmacol 785:144–155. https://doi.org/10.1016/j.ejphar.2015.11.001 article cas pubmed google scholar eiden le, weihe e (2011) vmat2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. ann n y acad sci 1216:86–98. https://doi.org/10.1111/j.1749-6632.2010.05906.x article cas pubmed pubmed central google scholar fda (2017) mydayis. https://pi.shirecontent.com/pi/pdfs/mydayis_usa_eng.pdf fda (2009) ritalin. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/010187s077lbl.pdf foley kf, desanty kp, kast re (2006) bupropion: pharmacology and therapeutic applications. expert rev neurother 6:1249–1265. https://doi.org/10.1586/14737175.6.9.1249 article cas pubmed google scholar freyberg z, sonders ms, aguilar ji, hiranita t, karam cs, flores j, pizzo ab, zhang y, farino zj, chen a, martin ca, kopajtic ta, fei h, hu g, lin yy, mosharov ev, mccabe bd, freyberg r, wimalasena k, hsin lw, sames d, krantz de, katz jl, sulzer d, javitch ja (2016) mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in drosophila brain. nat commun 7:10652. https://doi.org/10.1038/ncomms10652 article cas pubmed pubmed central google scholar garey jd, lusskin si, scialli ar (2020) teratogen update: amphetamines. birth defects res 112:1171–1182. https://doi.org/10.1002/bdr2.1774 article cas pubmed google scholar guillot ts, miller gw (2009) protective actions of the vesicular monoamine transporter 2 (vmat2) in monoaminergic neurons. mol neurobiol 39:149–170. https://doi.org/10.1007/s12035-009-8059-y article cas pubmed google scholar guillot ts, richardson jr, wang mz, li yj, taylor tn, ciliax bj, zachrisson o, mercer a, miller gw (2008) pacap38 increases vesicular monoamine transporter 2 (vmat2) expression and attenuates methamphetamine toxicity. neuropeptides 42:423–434. https://doi.org/10.1016/j.npep.2008.04.003 article cas pubmed pubmed central google scholar hauser j, makulska-gertruda e, reissmann a, sontag ta, tucha o, lange kw (2014) the effects of nutritional polyunsaturated fatty acids on locomotor activity in spontaneously hypertensive rats. atten defic hyperact disord 6:61–65. https://doi.org/10.1007/s12402-013-0125-7 article pubmed google scholar healy-stoffel m, levant b (2018) n-3 (omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders. cns neurol disord drug targets 17:216–232. https://doi.org/10.2174/1871527317666180412153612 article cas pubmed pubmed central google scholar heinzerling kg, swanson an, hall tm, yi y, wu y, shoptaw sj (2014) randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use. addiction 109:1878–1886. https://doi.org/10.1111/add.12636 article pubmed pubmed central google scholar hesse lm, venkatakrishnan k, court mh, von moltke ll, duan sx, shader ri, greenblatt dj (2000) cyp2b6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. drug metab dispos 28:1176–1183 cas pubmed google scholar huss m, duhan p, gandhi p, chen cw, spannhuth c, kumar v (2017) methylphenidate dose optimization for adhd treatment: review of safety, efficacy, and clinical necessity. neuropsychiatr dis treat 13:1741–1751. https://doi.org/10.2147/ndt.s130444 article cas pubmed pubmed central google scholar hutson ph, pennick m, secker r (2014) preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug. neuropharmacology 87:41–50. https://doi.org/10.1016/j.neuropharm.2014.02.014 article cas pubmed google scholar iwahashi m, yoshimura t, harigai w, takuma k, hashimoto h, katayama t, hayata-takano a (2023) pituitary adenylate cyclase-activating polypeptide deficient mice show length abnormalities of the axon initial segment. j pharmacol sci 153:175–182. https://doi.org/10.1016/j.jphs.2023.08.006 article cas pubmed google scholar kameg b, fradkin d (2021) management of attention-deficit/hyperactivity disorder in adults. j nurse pract 17:432–436. https://doi.org/10.1016/j.nurpra.2020.11.005 article google scholar kazda l, bell k, thomas r, mcgeechan k, sims r, barratt a (2021) overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic scoping review. jama netw open 4:e215335. https://doi.org/10.1001/jamanetworkopen.2021.5335 article pubmed pubmed central google scholar korchynska s, rebernik p, pende m, boi l, alpár a, tasan r, becker k, balueva k, saghafi s, wulff p, horvath tl, fisone g, dodt hu, hökfelt t, harkany t, romanov ra (2022) a hypothalamic dopamine locus for psychostimulant-induced hyperlocomotion in mice. nat commun 13:5944. https://doi.org/10.1038/s41467-022-33584-3 article cas pubmed pubmed central google scholar li y, yan x, li q, li q, xu g, lu j, yang w (2023) prevalence and trends in diagnosed adhd among us children and adolescents, 2017–2022. jama netw open 6:e2336872. https://doi.org/10.1001/jamanetworkopen.2023.36872 article pubmed pubmed central google scholar lu w, wolf me (1997) expression of dopamine transporter and vesicular monoamine transporter 2 mrnas in rat midbrain after repeated amphetamine administration. brain res mol brain res 49:137–148. https://doi.org/10.1016/s0169-328x(97)00136-8 article cas pubmed google scholar majarwitz dj, perumareddi p (2023) attention-deficit/hyperactivity disorder across the spectrum: from childhood to adulthood. prim care 50:21–36. https://doi.org/10.1016/j.pop.2022.10.004 article pubmed google scholar maneeton n, maneeton b, srisurapanont m, martin sd (2011) bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo‐controlled trials. psychiatry clin neurosci 65:611–617. https://doi.org/10.1111/j.1440-1819.2011.02264.x article pubmed google scholar martin ca, nuzzo pa, ranseen jd, kleven ms, guenthner g, williams y, walsh sl, dwoskin lp (2018) lobeline effects on cognitive performance in adult adhd. j atten disord 22:1361–1366. https://doi.org/10.1177/1087054713497791 article pubmed google scholar metz vg, segat hj, dias vt, barcelos rcs, maurer lh, stiebe j, emanuelli t, burger me, pase cs (2019) omega-3 decreases d1 and d2 receptors expression in the prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats. j nutr biochem 67:182–189. https://doi.org/10.1016/j.jnutbio.2019.02.007 article cas pubmed google scholar najib j (2009) the efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults. clin ther 31:142–176. https://doi.org/10.1016/j.clinthera.2009.01.015 article cas pubmed google scholar najib j, wimer d, zeng j, lam kw, romanyak n, paige morgan e, thadavila a (2017) review of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. j cent nerv syst dis 9:1179573517728090. https://doi.org/10.1177/1179573517728090 article cas pubmed pubmed central google scholar narendran r, frankle wg, mason ns, muldoon mf, moghaddam b (2012) improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation. plos one 7:e46832. https://doi.org/10.1371/journal.pone.0046832 article cas pubmed pubmed central google scholar ng qx (2017) a systematic review of the use of bupropion for attention-deficit/hyperactivity disorder in children and adolescents. j child adolesc psychopharmacol 27:112–116. https://doi.org/10.1089/cap.2016.0124 article cas pubmed google scholar nguyen m, shapiro ma, tharani s (2012) clinical utility of lisdexamfetamine for the management of attention-deficit hyperactivity disorder. clin med insights ther 4. https://doi.org/10.4137/cmt.s8706 nickell jr, siripurapu kb, vartak a, crooks pa, dwoskin lp (2014) the vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. adv pharmacol 69:71–106. https://doi.org/10.1016/b978-0-12-420118-7.00002-0 article cas pubmed pubmed central google scholar partilla js, dempsey ag, nagpal as, blough be, baumann mh, rothman rb (2006) interaction of amphetamines and related compounds at the vesicular monoamine transporter. j pharmacol exp ther 319:237–246. https://doi.org/10.1124/jpet.106.103622 article cas pubmed google scholar perera h, jeewandara kc, seneviratne s, guruge c (2012) combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (adhd) refractory to methylphenidate treatment: a double-blind, placebo-controlled study. j child neurol 27:747–753. https://doi.org/10.1177/0883073811435243 article pubmed google scholar quintero j, gutiérrez-casares jr, álamo c (2022) molecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on adhd neurobiology: a review. neurol ther 11:1489–1517. https://doi.org/10.1007/s40120-022-00392-2 article pubmed pubmed central google scholar rau ks, birdsall e, hanson je, johnson-davis kl, carroll fi, wilkins dg, gibb jw, hanson gr, fleckenstein ae (2005) bupropion increases striatal vesicular monoamine transport. neuropharmacology 49:820–830. https://doi.org/10.1016/j.neuropharm.2005.05.004 article cas pubmed google scholar reese mj, wurm rm, muir kt, generaux gt, st john-williams l, mcconn dj (2008) an in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug–drug interaction. drug metab dispos 36:1198–1201. https://doi.org/10.1124/dmd.107.020198 article cas pubmed google scholar riddle el, hanson gr, fleckenstein ae (2007) therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. eur j pharmacol 571:25–28. https://doi.org/10.1016/j.ejphar.2007.05.044 article cas pubmed pubmed central google scholar sandoval v, riddle el, hanson gr, fleckenstein ae (2002) methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. j neurosci 22:8705–8710. https://doi.org/10.1523/jneurosci.22-19-08705.2002 article cas pubmed pubmed central google scholar schwartz k, weizman a, rehavi m (2006) the effect of psychostimulants on [ 3 h]dopamine uptake and release in rat brain synaptic vesicles. j neural transm (vienna) 113:1347–1352. https://doi.org/10.1007/s00702-005-0383-4 article cas pubmed google scholar stahl sm (2014) stahl’s essential psychopharmacology. cambridge stahl sm, pradko jf, haight br, modell jg, rockett cb, learned-coughlin s (2004) a review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. prim care companion j clin psychiatry 6:159–166. https://doi.org/10.4088/pcc.v06n0403 article pubmed pubmed central google scholar støier jf, konomi-pilkati a, apuschkin m, herborg f, gether u (2023) amphetamine-induced reverse transport of dopamine does not require cytosolic ca 2+ . j biol chem 299:105063. https://doi.org/10.1016/j.jbc.2023.105063 article cas pubmed pubmed central google scholar strawn jr, picard ls (2017) triple-bead mixed amphetamine salt for adhd. curr psychiatry 16:33–37 google scholar sulzer d, rayport s (1990) amphetamine and other psychostimulants reduce ph gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. neuron 5:797–808. https://doi.org/10.1016/0896-6273(90)90339-h article cas pubmed google scholar teng lh, crooks pa, sonsalla pk, dwoskin lp (1997) lobeline and nicotine evoke [ 3 h]overflow from rat striatal slices preloaded with [ 3 h]dopamine: differential inhibition of synaptosomal and vesicular [ 3 h]dopamine uptake. j pharmacol exp ther 280:1432–1444 cas pubmed google scholar teng b, murthy ks, kuemmerle jf, grider jr, makhlouf gm (1998) selective expression of vasoactive intestinal peptide (vip)2/pituitary adenylate cyclase-activating polypeptide (pacap)3 receptors in rabbit and guinea pig gastric and tenia coli smooth muscle cells. regul pept 77:127–134. https://doi.org/10.1016/s0167-0115(98)00112-8 article cas pubmed google scholar toren p, rehavi m, luski a, roz n, laor n, lask m, weizman a (2005) decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder. eur neuropsychopharmacol 15:159–162. https://doi.org/10.1016/j.euroneuro.2004.07.002 article cas pubmed google scholar vaudry d, gonzalez bj, basille m, yon l, fournier a, vaudry h (2000) pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. pharmacol rev 52:269–324 cas pubmed google scholar velasco er, florido a, flores á, senabre e, gomez-gomez a, torres a, roca a, norrholm s, newman el, das p, ross ra, lori a, pozo oj, ressler kj, garcia-esteve ll, jovanovic t, andero r (2022) pacap-pac1r modulates fear extinction via the ventromedial hypothalamus. nat commun 13:4374. https://doi.org/10.1038/s41467-022-31442-w article cas pubmed pubmed central google scholar verbeeck w, bekkering ge, van den noortgate w, kramers c (2017) bupropion for attention deficit hyperactivity disorder (adhd) in adults. cochrane database syst rev 10:cd009504. https://doi.org/10.1002/14651858.cd009504.pub2 article pubmed google scholar wang g, pan j, tan yy, sun xk, zhang yf, zhou hy, ren rj, wang xj, chen sd (2008) neuroprotective effects of pacap27 in mice model of parkinson’s disease involved in the modulation of k(atp) subunits and d2 receptors in the striatum. neuropeptides 42:267–276. https://doi.org/10.1016/j.npep.2008.03.002 article cas pubmed google scholar wimalasena k (2011) vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry. med res rev 31:483–519. https://doi.org/10.1002/med.20187 article cas pubmed google scholar download references acknowledgements we thank editage ( www.editage.com ) for english language editing. funding not applicable. author information authors and affiliations dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa halford warlick iv, sukriti prashar, erick boldt, alena khalil, simran arora, thomas matthews, talha wahid, richard fernandez, dhiya ram &amp; lexie leon dr. kiran c. patel college of allopathic medicine, health profession division, nova southeastern university, fort lauderdale, florida, usa darcy tocci &amp; kelley davis college of pharmacy, health profession division, nova southeastern university, fort lauderdale, florida, usa jose rey halmos college of arts and sciences, nova southeastern university, fort lauderdale, florida, usa arisha arain authors halford warlick iv view author publications search author on: pubmed google scholar darcy tocci view author publications search author on: pubmed google scholar sukriti prashar view author publications search author on: pubmed google scholar erick boldt view author publications search author on: pubmed google scholar alena khalil view author publications search author on: pubmed google scholar simran arora view author publications search author on: pubmed google scholar thomas matthews view author publications search author on: pubmed google scholar talha wahid view author publications search author on: pubmed google scholar richard fernandez view author publications search author on: pubmed google scholar dhiya ram view author publications search author on: pubmed google scholar lexie leon view author publications search author on: pubmed google scholar arisha arain view author publications search author on: pubmed google scholar jose rey view author publications search author on: pubmed google scholar kelley davis view author publications search author on: pubmed google scholar corresponding author correspondence to halford warlick iv . ethics declarations conflict of interest not applicable. additional information publisher’s note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. rights and permissions springer nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. reprints and permissions about this article cite this article warlick iv, h., tocci, d., prashar, s. et al. role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review. psychopharmacology 241 , 2191–2203 (2024). https://doi.org/10.1007/s00213-024-06686-7 download citation received : 19 january 2024 accepted : 05 september 2024 published : 20 september 2024 issue date : november 2024 doi : https://doi.org/10.1007/s00213-024-06686-7 share this article anyone you share the following link with will be able to read this content: get shareable link sorry, a shareable link is not currently available for this article. copy shareable link to clipboard provided by the springer nature sharedit content-sharing initiative keywords attention deficit hyperactivity disorder vesicular monoamine transporter neurodevelopmental disorder amphetamines methylphenidate omega-3 fatty acids bupropion norepinephrine dopamine ph gradient model profiles halford warlick iv view author profile access this article log in via an institution subscribe and save springer+ from $39.99 /month starting from 10 chapters or articles per month access and download chapters and articles from more than 300k books and 2,500 journals cancel anytime view plans buy now buy article pdf usd 39.95 price excludes vat (usa) tax calculation will be finalised during checkout. instant access to the full article pdf. datalayer.push({"ecommerce":{"currency":"usd","impressions":[{"name":"role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review","id":"1432-2072","price":39.95,"brand":"springer berlin heidelberg","category":"neuroscience","variant":"ppv-article","quantity":1}]}}); ;(function () { if (window.localstorage) { window.localstorage.removeitem("springerplusrollout") } })() .springer-plus .buying-option-usps > li::before { background-image: url("data:image/svg+xml,%3csvg viewbox='0 0 100 100' xmlns='http://www.w3.org/2000/svg' fill='%230070a8'%3e%3ccircle cx='50' cy='50' r='50'/%3e%3c/svg%3e"); } institutional subscriptions .sprcom-buybox-articledarwin .buybox__access-option{ border-top: 1px solid #cedbe0; font-size: 1rem; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus{ background-color: #ebf6ff; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus-headline{ display: flex; justify-content: space-between; } .sprcom-buybox-articledarwin .springer-plus-heading{ border-bottom: 1px solid #c5e0f4; border-top: 1px solid #c5e0f4; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; font-size: 1.125rem; font-weight: 700; margin: 0; padding: 16px; text-align: center; } .sprcom-buybox-articledarwin .springer-plus-title{ align-items: center; display: flex; } .sprcom-buybox-articledarwin .springer-plus-title span{ margin-left: 8px; } .sprcom-buybox-articledarwin .springer-plus a{ background-color: #fff; border: 1px solid #025e8d; color: #025e8d; font-size: 16px; font-weight: 700; max-height: 44px; } .sprcom-buybox-articledarwin .springer-plus a span{ margin-right: 8px; } .sprcom-buybox-articledarwin .springer-plus a:hover{ background-color: #025e8d; border: 4px solid #025e8d; box-shadow: none; color: #fff; font-weight: 700; } .sprcom-buybox-articledarwin .springer-plus a:visited{ color: #025e8d; } .sprcom-buybox-articledarwin .springer-plus a:visited:hover{ color: #fff; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps{ color: #555; font-size: 1rem; line-height: 1.6; list-style: none; margin: 0; padding: 16px 0 24px 0; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li{ padding-left: 26px; position: relative; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li::before{ content: ''; height: 10px; left: 0; position: absolute; top: calc(0.8em - 5px); width: 10px; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li:not(:first-child){ margin-top: 4px; } advertisement window.sn = window.sn || {}; window.sn.libs = window.sn.libs || {}; window.sn.libs.ads = window.sn.libs.ads || {}; window.sn.libs.ads.slotconfig = window.sn.libs.ads.slotconfig || {}; window.sn.libs.ads.slotconfig['mpu1'] = { 'pos': 'mpu1', 'type': 'mpu1', }; window.sn.libs.ads.slotconfig['unitpath'] = '/270604982/springerlink/213/article'; search search by keyword or author search navigation find a journal publish with us track your research discover content journals a-z books a-z publish with us journal finder publish your research language editing open access publishing products and services our products librarians societies partners and advertisers our brands springer nature portfolio bmc palgrave macmillan apress discover your privacy choices/manage cookies your us state privacy rights accessibility statement terms and conditions privacy policy help and support legal notice cancel contracts here 52.88.153.61 not affiliated &copy; 2025 springer nature

## Results
of these studies, we observed that stimulants interact highly with the vmat-2 transporter, with omega-3 fatty acids, peptides, and bupropion exerting some modulatory activity on vmat-2. these agents should be considered for the future treatment of adhd, although clinical-level research involving human participants is necessary.","datepublished":"2024-09-20t00:00:00z","datemodified":"2024-09-20t00:00:00z","pagestart":"2191","pageend":"2203","sameas":"https://doi.org/10.1007/s00213-024-06686-7","keywords":["attention deficit hyperactivity disorder","vesicular monoamine transporter","neurodevelopmental disorder","amphetamines","methylphenidate","omega-3 fatty acids","bupropion","norepinephrine","dopamine","ph gradient model","neurosciences","pharmacology/toxicology","psychiatry"],"image":["https://media.springernature.com/lw1200/springer-static/image/art%3a10.1007%2fs00213-024-06686-7/mediaobjects/213_2024_6686_figb_html.png","https://media.springernature.com/lw1200/springer-static/image/art%3a10.1007%2fs00213-024-06686-7/mediaobjects/213_2024_6686_figa_html.png"],"ispartof":{"name":"psychopharmacology","issn":["1432-2072","0033-3158"],"volumenumber":"241","@type":["periodical","publicationvolume"]},"publisher":{"name":"springer berlin heidelberg","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"imageobject"},"@type":"organization"},"author":[{"name":"halford warlick iv","url":"http://orcid.org/0000-0003-1643-2011","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"email":"halfordwarlick@yahoo.com","@type":"person"},{"name":"darcy tocci","affiliation":[{"name":"health profession division, nova southeastern university, fort lauderdale","address":{"name":"dr. kiran c. patel college of allopathic medicine, health profession division, nova southeastern university, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"sukriti prashar","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"erick boldt","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"alena khalil","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"simran arora","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"thomas matthews","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"talha wahid","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"richard fernandez","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"dhiya ram","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"lexie leon","affiliation":[{"name":"dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale","address":{"name":"dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"arisha arain","affiliation":[{"name":"halmos college of arts and sciences, nova southeastern university, fort lauderdale","address":{"name":"halmos college of arts and sciences, nova southeastern university, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"jose rey","affiliation":[{"name":" health profession division, nova southeastern university, fort lauderdale","address":{"name":"college of pharmacy, health profession division, nova southeastern university, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"},{"name":"kelley davis","affiliation":[{"name":"health profession division, nova southeastern university, fort lauderdale","address":{"name":"dr. kiran c. patel college of allopathic medicine, health profession division, nova southeastern university, fort lauderdale, florida, usa","@type":"postaladdress"},"@type":"organization"}],"@type":"person"}],"isaccessibleforfree":false,"haspart":{"isaccessibleforfree":false,"cssselector":".main-content","@type":"webpageelement"},"@type":"scholarlyarticle"},"@context":"https://schema.org","@type":"webpage"} skip to main content advertisement window.sn = window.sn || {}; window.sn.libs = window.sn.libs || {}; window.sn.libs.ads = window.sn.libs.ads || {}; window.sn.libs.ads.slotconfig = window.sn.libs.ads.slotconfig || {}; window.sn.libs.ads.slotconfig['lb1'] = { 'pos': 'top', 'type': 'top', }; window.sn.libs.ads.slotconfig['unitpath'] = '/270604982/springerlink/213/article'; log in menu find a journal publish with us track your research search cart (function () { var exports = {}; if (window.fetch) { "use strict"; object.defineproperty(exports, "__esmodule", { value: true }); exports.headerwidgetclientinit = void 0; var headerwidgetclientinit = function (getcartinfo) { document.body.addeventlistener("updatedcart", function () { updatecarticon(); }, false); return updatecarticon(); function updatecarticon() { return getcartinfo() .then(function (res) { return res.json(); }) .then(refreshcartstate) .catch(function (_) { }); } function refreshcartstate(json) { var indicator = document.queryselector("#ecommerce-header-cart-icon-link .cart-info"); /* istanbul ignore else */ if (indicator && json.itemcount) { indicator.style.display = 'block'; indicator.textcontent = json.itemcount > 9 ? '9+' : json.itemcount.tostring(); var morethanoneitem = json.itemcount > 1; indicator.setattribute('title', "there ".concat(morethanoneitem ? "are" : "is", " ").concat(json.itemcount, " item").concat(morethanoneitem ? "s" : "", " in your cart")); } return json; } }; exports.headerwidgetclientinit = headerwidgetclientinit; headerwidgetclientinit( function () { return window.fetch("https://cart.springer.com/cart-info", { credentials: "include", headers: { accept: "application/json" } }) } ) }})() home psychopharmacology article role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review review published: 20 september 2024 volume 241 , pages 2191–2203, ( 2024 ) cite this article psychopharmacology aims and scope submit manuscript halford warlick iv orcid: orcid.org/0000-0003-1643-2011 1 , darcy tocci 2 , sukriti prashar 1 , erick boldt 1 , alena khalil 1 , simran arora 1 , thomas matthews 1 , talha wahid 1 , richard fernandez 1 , dhiya ram 1 , lexie leon 1 , arisha arain 4 , jose rey 3 &amp; … kelley davis 2 show authors 1062 accesses 6 altmetric explore all metrics abstract rationale the diagnostic and statistical manual of mental disorders (fifth edition) classifies attention deficit hyperactivity disorder (adhd) as a neurodevelopmental disorder that interferes with human functioning and development. as the clinical presentation of adhd involves a deficiency in executive function, neurocognitive deficits involving distinctive neuropathological changes must be present for clinical diagnosis. objectives the vesicular monoamine transporter (vmat), specifically vmat-2, plays a role in adhd pathogenesis. in addition, experimental data show that the stimulants (amphetamines and methylphenidate) are first-line treatments for the condition because of their extensive interaction with vmat-2. the interactions of peptides, bupropion, and nutritional supplements with vmat-2 receptors have been researched, but more evidence is needed to elucidate their pharmacodynamic properties. therefore, this literature review evaluated the current pharmacological treatment modalities, peptides, and nutritional supplements for adhd that target the vmat-2 system. methods, results, and conclusions we obtained relevant studies from several platforms, including the national center for biotechnology, clinical key, access medicine, and pubmed. from the results of these studies, we observed that stimulants interact highly with the vmat-2 transporter, with omega-3 fatty acids, peptides, and bupropion exerting some modulatory activity on vmat-2. these agents should be considered for the future treatment of adhd, although clinical-level research involving human participants is necessary. this is a preview of subscription content, log in via an institution to check access. access this article log in via an institution subscribe and save springer+ from $39.99 /month starting from 10 chapters or articles per month access and download chapters and articles from more than 300k books and 2,500 journals cancel anytime view plans buy now buy article pdf usd 39.95 price excludes vat (usa) tax calculation will be finalised during checkout. instant access to the full article pdf. datalayer.push({"ecommerce":{"currency":"usd","impressions":[{"name":"role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review","id":"1432-2072","price":39.95,"brand":"springer berlin heidelberg","category":"neuroscience","variant":"ppv-article","quantity":1}]}}); ;(function () { if (window.localstorage) { window.localstorage.removeitem("springerplusrollout") } })() .springer-plus .buying-option-usps > li::before { background-image: url("data:image/svg+xml,%3csvg viewbox='0 0 100 100' xmlns='http://www.w3.org/2000/svg' fill='%230070a8'%3e%3ccircle cx='50' cy='50' r='50'/%3e%3c/svg%3e"); } institutional subscriptions .sprcom-buybox-articledarwin .buybox__access-option{ border-top: 1px solid #cedbe0; font-size: 1rem; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus{ background-color: #ebf6ff; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus-headline{ display: flex; justify-content: space-between; } .sprcom-buybox-articledarwin .springer-plus-heading{ border-bottom: 1px solid #c5e0f4; border-top: 1px solid #c5e0f4; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; font-size: 1.125rem; font-weight: 700; margin: 0; padding: 16px; text-align: center; } .sprcom-buybox-articledarwin .springer-plus-title{ align-items: center; display: flex; } .sprcom-buybox-articledarwin .springer-plus-title span{ margin-left: 8px; } .sprcom-buybox-articledarwin .springer-plus a{ background-color: #fff; border: 1px solid #025e8d; color: #025e8d; font-size: 16px; font-weight: 700; max-height: 44px; } .sprcom-buybox-articledarwin .springer-plus a span{ margin-right: 8px; } .sprcom-buybox-articledarwin .springer-plus a:hover{ background-color: #025e8d; border: 4px solid #025e8d; box-shadow: none; color: #fff; font-weight: 700; } .sprcom-buybox-articledarwin .springer-plus a:visited{ color: #025e8d; } .sprcom-buybox-articledarwin .springer-plus a:visited:hover{ color: #fff; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps{ color: #555; font-size: 1rem; line-height: 1.6; list-style: none; margin: 0; padding: 16px 0 24px 0; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li{ padding-left: 26px; position: relative; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li::before{ content: ''; height: 10px; left: 0; position: absolute; top: calc(0.8em - 5px); width: 10px; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li:not(:first-child){ margin-top: 4px; } fig. 1 fig. 2 similar content being viewed by others mechanisms of neurotransmitter transport and drug inhibition in human vmat2 article 01 november 2023 transport and inhibition mechanism for vmat2-mediated synaptic vesicle loading of monoamines article open access 02 january 2024 drug inhibition and substrate transport mechanisms of human vmat2 article open access 02 january 2025 window.datalayer = window.datalayer || []; window.datalayer.push({ recommendations: { recommender: 'semantic', model: 'specter', policy_id: 'na', timestamp: 1761044444, embedded_user: 'null' } }); explore related subjects discover the latest articles, books and news in related subjects, suggested using machine learning. adhd attention deficit disorder drug therapy neuropharmacology transporters in the nervous system transport vesicle references adler la, dirks b, deas pf, raychaudhuri a, dauphin mr, lasser ra, weisler rh (2013) lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. j clin psychiatry 74:694–702. https://doi.org/10.4088/jcp.12m08144 article cas pubmed google scholar alwindi m, bizanti a (2023) vesicular monoamine transporter (vmat) regional expression and roles in pathological conditions. heliyon 9:e22413. https://doi.org/10.1016/j.heliyon.2023.e22413 article cas pubmed pubmed central google scholar barlow rb, johnson o (1989) relations between structure and nicotine-like activity: x-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds. br j pharmacol 98:799–808. https://doi.org/10.1111/j.1476-5381.1989.tb14608.x article cas pubmed pubmed central google scholar barragán e, breuer d, döpfner m (2017) efficacy and safety of omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with adhd. j atten disord 21:433–441. https://doi.org/10.1177/1087054713518239 article pubmed google scholar biederman j, fried r, hammerness p, surman c, mehler b, petty cr, faraone sv, miller c, bourgeois m, meller b, godfrey km, reimer b (2012) the effects of lisdexamfetamine dimesylate on the driving performance of young adults with adhd: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. j psychiatr res 46:484–491. https://doi.org/10.1016/j.jpsychires.2012.01.007 article pubmed google scholar blick ska, keating gm (2007) lisdexamfetamine. paediatr drugs 9:129–135 discussion 136. https://doi.org/10.2165/00148581-200709020-00007 article pubmed google scholar blum k, chen alc, braverman er, comings de, chen tjh, arcuri v, blum sh, downs bw, waite rl, notaro a, lubar j, williams l, prihoda tj, palomo t, oscar-berman m (2008) attention-deficit-hyperactivity disorder and reward deficiency syndrome. neuropsychiatr dis treat 4:893–918. https://doi.org/10.2147/ndt.s2627 article pubmed pubmed central google scholar bristot g, ascoli bm, scotton e, géa lp, pfaffenseller b, kauer-sant’anna m (2019) effects of lithium on inflammatory and neurotrophic factors after an immune challenge in a lisdexamfetamine animal model of mania. braz j psychiatry 41:419–427. https://doi.org/10.1590/1516-4446-2017-0001 article pubmed pubmed central google scholar burns c, kidron a (eds) (2022) biochemistry, tyramine. statpearls. internet. in: statpearls publishing, treasure island (fl), p 2024 jan-. https://www.ncbi.nlm.nih.gov/books/nbk563197/ comiran e, kessler fh, fröehlich pe, limberger rp (2016) lisdexamfetamine: a pharmacokinetic review. eur j pharm sci 89:172–179. https://doi.org/10.1016/j.ejps.2016.04.026 article cas pubmed google scholar crooks pa, zheng g, vartak ap, culver jp, zheng f, horton db, dwoskin lp (2011) design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse. curr top med chem 11:1103–1127. https://doi.org/10.2174/156802611795371332 article cas pubmed pubmed central google scholar dhillon s, yang lph, curran mp (2008) bupropion: a review of its use in the management of major depressive disorder. drugs 68:653–689. https://doi.org/10.2165/00003495-200868050-00011 article cas pubmed google scholar di miceli m, derf a, gronier b (2022) consequences of acute or chronic methylphenidate exposure using ex vivo neurochemistry and in vivo electrophysiology in the prefrontal cortex and striatum of rats. int j mol sci 23:8588. https://doi.org/10.3390/ijms23158588 article cas pubmed pubmed central google scholar dupaul gj, weyandt ll, rossi js, vilardo ba, o’dell sm, carson km, verdi g, swentosky a (2012) double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with adhd. j atten disord 16:202–220. https://doi.org/10.1177/1087054711427299 article pubmed google scholar duvall mg, levy bd (2016) dha- and epa-derived resolvins, protectins, and maresins in airway inflammation. eur j pharmacol 785:144–155. https://doi.org/10.1016/j.ejphar.2015.11.001 article cas pubmed google scholar eiden le, weihe e (2011) vmat2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. ann n y acad sci 1216:86–98. https://doi.org/10.1111/j.1749-6632.2010.05906.x article cas pubmed pubmed central google scholar fda (2017) mydayis. https://pi.shirecontent.com/pi/pdfs/mydayis_usa_eng.pdf fda (2009) ritalin. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/010187s077lbl.pdf foley kf, desanty kp, kast re (2006) bupropion: pharmacology and therapeutic applications. expert rev neurother 6:1249–1265. https://doi.org/10.1586/14737175.6.9.1249 article cas pubmed google scholar freyberg z, sonders ms, aguilar ji, hiranita t, karam cs, flores j, pizzo ab, zhang y, farino zj, chen a, martin ca, kopajtic ta, fei h, hu g, lin yy, mosharov ev, mccabe bd, freyberg r, wimalasena k, hsin lw, sames d, krantz de, katz jl, sulzer d, javitch ja (2016) mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in drosophila brain. nat commun 7:10652. https://doi.org/10.1038/ncomms10652 article cas pubmed pubmed central google scholar garey jd, lusskin si, scialli ar (2020) teratogen update: amphetamines. birth defects res 112:1171–1182. https://doi.org/10.1002/bdr2.1774 article cas pubmed google scholar guillot ts, miller gw (2009) protective actions of the vesicular monoamine transporter 2 (vmat2) in monoaminergic neurons. mol neurobiol 39:149–170. https://doi.org/10.1007/s12035-009-8059-y article cas pubmed google scholar guillot ts, richardson jr, wang mz, li yj, taylor tn, ciliax bj, zachrisson o, mercer a, miller gw (2008) pacap38 increases vesicular monoamine transporter 2 (vmat2) expression and attenuates methamphetamine toxicity. neuropeptides 42:423–434. https://doi.org/10.1016/j.npep.2008.04.003 article cas pubmed pubmed central google scholar hauser j, makulska-gertruda e, reissmann a, sontag ta, tucha o, lange kw (2014) the effects of nutritional polyunsaturated fatty acids on locomotor activity in spontaneously hypertensive rats. atten defic hyperact disord 6:61–65. https://doi.org/10.1007/s12402-013-0125-7 article pubmed google scholar healy-stoffel m, levant b (2018) n-3 (omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders. cns neurol disord drug targets 17:216–232. https://doi.org/10.2174/1871527317666180412153612 article cas pubmed pubmed central google scholar heinzerling kg, swanson an, hall tm, yi y, wu y, shoptaw sj (2014) randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use. addiction 109:1878–1886. https://doi.org/10.1111/add.12636 article pubmed pubmed central google scholar hesse lm, venkatakrishnan k, court mh, von moltke ll, duan sx, shader ri, greenblatt dj (2000) cyp2b6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. drug metab dispos 28:1176–1183 cas pubmed google scholar huss m, duhan p, gandhi p, chen cw, spannhuth c, kumar v (2017) methylphenidate dose optimization for adhd treatment: review of safety, efficacy, and clinical necessity. neuropsychiatr dis treat 13:1741–1751. https://doi.org/10.2147/ndt.s130444 article cas pubmed pubmed central google scholar hutson ph, pennick m, secker r (2014) preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug. neuropharmacology 87:41–50. https://doi.org/10.1016/j.neuropharm.2014.02.014 article cas pubmed google scholar iwahashi m, yoshimura t, harigai w, takuma k, hashimoto h, katayama t, hayata-takano a (2023) pituitary adenylate cyclase-activating polypeptide deficient mice show length abnormalities of the axon initial segment. j pharmacol sci 153:175–182. https://doi.org/10.1016/j.jphs.2023.08.006 article cas pubmed google scholar kameg b, fradkin d (2021) management of attention-deficit/hyperactivity disorder in adults. j nurse pract 17:432–436. https://doi.org/10.1016/j.nurpra.2020.11.005 article google scholar kazda l, bell k, thomas r, mcgeechan k, sims r, barratt a (2021) overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic scoping review. jama netw open 4:e215335. https://doi.org/10.1001/jamanetworkopen.2021.5335 article pubmed pubmed central google scholar korchynska s, rebernik p, pende m, boi l, alpár a, tasan r, becker k, balueva k, saghafi s, wulff p, horvath tl, fisone g, dodt hu, hökfelt t, harkany t, romanov ra (2022) a hypothalamic dopamine locus for psychostimulant-induced hyperlocomotion in mice. nat commun 13:5944. https://doi.org/10.1038/s41467-022-33584-3 article cas pubmed pubmed central google scholar li y, yan x, li q, li q, xu g, lu j, yang w (2023) prevalence and trends in diagnosed adhd among us children and adolescents, 2017–2022. jama netw open 6:e2336872. https://doi.org/10.1001/jamanetworkopen.2023.36872 article pubmed pubmed central google scholar lu w, wolf me (1997) expression of dopamine transporter and vesicular monoamine transporter 2 mrnas in rat midbrain after repeated amphetamine administration. brain res mol brain res 49:137–148. https://doi.org/10.1016/s0169-328x(97)00136-8 article cas pubmed google scholar majarwitz dj, perumareddi p (2023) attention-deficit/hyperactivity disorder across the spectrum: from childhood to adulthood. prim care 50:21–36. https://doi.org/10.1016/j.pop.2022.10.004 article pubmed google scholar maneeton n, maneeton b, srisurapanont m, martin sd (2011) bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo‐controlled trials. psychiatry clin neurosci 65:611–617. https://doi.org/10.1111/j.1440-1819.2011.02264.x article pubmed google scholar martin ca, nuzzo pa, ranseen jd, kleven ms, guenthner g, williams y, walsh sl, dwoskin lp (2018) lobeline effects on cognitive performance in adult adhd. j atten disord 22:1361–1366. https://doi.org/10.1177/1087054713497791 article pubmed google scholar metz vg, segat hj, dias vt, barcelos rcs, maurer lh, stiebe j, emanuelli t, burger me, pase cs (2019) omega-3 decreases d1 and d2 receptors expression in the prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats. j nutr biochem 67:182–189. https://doi.org/10.1016/j.jnutbio.2019.02.007 article cas pubmed google scholar najib j (2009) the efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults. clin ther 31:142–176. https://doi.org/10.1016/j.clinthera.2009.01.015 article cas pubmed google scholar najib j, wimer d, zeng j, lam kw, romanyak n, paige morgan e, thadavila a (2017) review of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. j cent nerv syst dis 9:1179573517728090. https://doi.org/10.1177/1179573517728090 article cas pubmed pubmed central google scholar narendran r, frankle wg, mason ns, muldoon mf, moghaddam b (2012) improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation. plos one 7:e46832. https://doi.org/10.1371/journal.pone.0046832 article cas pubmed pubmed central google scholar ng qx (2017) a systematic review of the use of bupropion for attention-deficit/hyperactivity disorder in children and adolescents. j child adolesc psychopharmacol 27:112–116. https://doi.org/10.1089/cap.2016.0124 article cas pubmed google scholar nguyen m, shapiro ma, tharani s (2012) clinical utility of lisdexamfetamine for the management of attention-deficit hyperactivity disorder. clin med insights ther 4. https://doi.org/10.4137/cmt.s8706 nickell jr, siripurapu kb, vartak a, crooks pa, dwoskin lp (2014) the vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. adv pharmacol 69:71–106. https://doi.org/10.1016/b978-0-12-420118-7.00002-0 article cas pubmed pubmed central google scholar partilla js, dempsey ag, nagpal as, blough be, baumann mh, rothman rb (2006) interaction of amphetamines and related compounds at the vesicular monoamine transporter. j pharmacol exp ther 319:237–246. https://doi.org/10.1124/jpet.106.103622 article cas pubmed google scholar perera h, jeewandara kc, seneviratne s, guruge c (2012) combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (adhd) refractory to methylphenidate treatment: a double-blind, placebo-controlled study. j child neurol 27:747–753. https://doi.org/10.1177/0883073811435243 article pubmed google scholar quintero j, gutiérrez-casares jr, álamo c (2022) molecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on adhd neurobiology: a review. neurol ther 11:1489–1517. https://doi.org/10.1007/s40120-022-00392-2 article pubmed pubmed central google scholar rau ks, birdsall e, hanson je, johnson-davis kl, carroll fi, wilkins dg, gibb jw, hanson gr, fleckenstein ae (2005) bupropion increases striatal vesicular monoamine transport. neuropharmacology 49:820–830. https://doi.org/10.1016/j.neuropharm.2005.05.004 article cas pubmed google scholar reese mj, wurm rm, muir kt, generaux gt, st john-williams l, mcconn dj (2008) an in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug–drug interaction. drug metab dispos 36:1198–1201. https://doi.org/10.1124/dmd.107.020198 article cas pubmed google scholar riddle el, hanson gr, fleckenstein ae (2007) therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. eur j pharmacol 571:25–28. https://doi.org/10.1016/j.ejphar.2007.05.044 article cas pubmed pubmed central google scholar sandoval v, riddle el, hanson gr, fleckenstein ae (2002) methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. j neurosci 22:8705–8710. https://doi.org/10.1523/jneurosci.22-19-08705.2002 article cas pubmed pubmed central google scholar schwartz k, weizman a, rehavi m (2006) the effect of psychostimulants on [ 3 h]dopamine uptake and release in rat brain synaptic vesicles. j neural transm (vienna) 113:1347–1352. https://doi.org/10.1007/s00702-005-0383-4 article cas pubmed google scholar stahl sm (2014) stahl’s essential psychopharmacology. cambridge stahl sm, pradko jf, haight br, modell jg, rockett cb, learned-coughlin s (2004) a review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. prim care companion j clin psychiatry 6:159–166. https://doi.org/10.4088/pcc.v06n0403 article pubmed pubmed central google scholar støier jf, konomi-pilkati a, apuschkin m, herborg f, gether u (2023) amphetamine-induced reverse transport of dopamine does not require cytosolic ca 2+ . j biol chem 299:105063. https://doi.org/10.1016/j.jbc.2023.105063 article cas pubmed pubmed central google scholar strawn jr, picard ls (2017) triple-bead mixed amphetamine salt for adhd. curr psychiatry 16:33–37 google scholar sulzer d, rayport s (1990) amphetamine and other psychostimulants reduce ph gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. neuron 5:797–808. https://doi.org/10.1016/0896-6273(90)90339-h article cas pubmed google scholar teng lh, crooks pa, sonsalla pk, dwoskin lp (1997) lobeline and nicotine evoke [ 3 h]overflow from rat striatal slices preloaded with [ 3 h]dopamine: differential inhibition of synaptosomal and vesicular [ 3 h]dopamine uptake. j pharmacol exp ther 280:1432–1444 cas pubmed google scholar teng b, murthy ks, kuemmerle jf, grider jr, makhlouf gm (1998) selective expression of vasoactive intestinal peptide (vip)2/pituitary adenylate cyclase-activating polypeptide (pacap)3 receptors in rabbit and guinea pig gastric and tenia coli smooth muscle cells. regul pept 77:127–134. https://doi.org/10.1016/s0167-0115(98)00112-8 article cas pubmed google scholar toren p, rehavi m, luski a, roz n, laor n, lask m, weizman a (2005) decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder. eur neuropsychopharmacol 15:159–162. https://doi.org/10.1016/j.euroneuro.2004.07.002 article cas pubmed google scholar vaudry d, gonzalez bj, basille m, yon l, fournier a, vaudry h (2000) pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. pharmacol rev 52:269–324 cas pubmed google scholar velasco er, florido a, flores á, senabre e, gomez-gomez a, torres a, roca a, norrholm s, newman el, das p, ross ra, lori a, pozo oj, ressler kj, garcia-esteve ll, jovanovic t, andero r (2022) pacap-pac1r modulates fear extinction via the ventromedial hypothalamus. nat commun 13:4374. https://doi.org/10.1038/s41467-022-31442-w article cas pubmed pubmed central google scholar verbeeck w, bekkering ge, van den noortgate w, kramers c (2017) bupropion for attention deficit hyperactivity disorder (adhd) in adults. cochrane database syst rev 10:cd009504. https://doi.org/10.1002/14651858.cd009504.pub2 article pubmed google scholar wang g, pan j, tan yy, sun xk, zhang yf, zhou hy, ren rj, wang xj, chen sd (2008) neuroprotective effects of pacap27 in mice model of parkinson’s disease involved in the modulation of k(atp) subunits and d2 receptors in the striatum. neuropeptides 42:267–276. https://doi.org/10.1016/j.npep.2008.03.002 article cas pubmed google scholar wimalasena k (2011) vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry. med res rev 31:483–519. https://doi.org/10.1002/med.20187 article cas pubmed google scholar download references acknowledgements we thank editage ( www.editage.com ) for english language editing. funding not applicable. author information authors and affiliations dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa halford warlick iv, sukriti prashar, erick boldt, alena khalil, simran arora, thomas matthews, talha wahid, richard fernandez, dhiya ram &amp; lexie leon dr. kiran c. patel college of allopathic medicine, health profession division, nova southeastern university, fort lauderdale, florida, usa darcy tocci &amp; kelley davis college of pharmacy, health profession division, nova southeastern university, fort lauderdale, florida, usa jose rey halmos college of arts and sciences, nova southeastern university, fort lauderdale, florida, usa arisha arain authors halford warlick iv view author publications search author on: pubmed google scholar darcy tocci view author publications search author on: pubmed google scholar sukriti prashar view author publications search author on: pubmed google scholar erick boldt view author publications search author on: pubmed google scholar alena khalil view author publications search author on: pubmed google scholar simran arora view author publications search author on: pubmed google scholar thomas matthews view author publications search author on: pubmed google scholar talha wahid view author publications search author on: pubmed google scholar richard fernandez view author publications search author on: pubmed google scholar dhiya ram view author publications search author on: pubmed google scholar lexie leon view author publications search author on: pubmed google scholar arisha arain view author publications search author on: pubmed google scholar jose rey view author publications search author on: pubmed google scholar kelley davis view author publications search author on: pubmed google scholar corresponding author correspondence to halford warlick iv . ethics declarations conflict of interest not applicable. additional information publisher’s note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. rights and permissions springer nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. reprints and permissions about this article cite this article warlick iv, h., tocci, d., prashar, s. et al. role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review. psychopharmacology 241 , 2191–2203 (2024). https://doi.org/10.1007/s00213-024-06686-7 download citation received : 19 january 2024 accepted : 05 september 2024 published : 20 september 2024 issue date : november 2024 doi : https://doi.org/10.1007/s00213-024-06686-7 share this article anyone you share the following link with will be able to read this content: get shareable link sorry, a shareable link is not currently available for this article. copy shareable link to clipboard provided by the springer nature sharedit content-sharing initiative keywords attention deficit hyperactivity disorder vesicular monoamine transporter neurodevelopmental disorder amphetamines methylphenidate omega-3 fatty acids bupropion norepinephrine dopamine ph gradient model profiles halford warlick iv view author profile access this article log in via an institution subscribe and save springer+ from $39.99 /month starting from 10 chapters or articles per month access and download chapters and articles from more than 300k books and 2,500 journals cancel anytime view plans buy now buy article pdf usd 39.95 price excludes vat (usa) tax calculation will be finalised during checkout. instant access to the full article pdf. datalayer.push({"ecommerce":{"currency":"usd","impressions":[{"name":"role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review","id":"1432-2072","price":39.95,"brand":"springer berlin heidelberg","category":"neuroscience","variant":"ppv-article","quantity":1}]}}); ;(function () { if (window.localstorage) { window.localstorage.removeitem("springerplusrollout") } })() .springer-plus .buying-option-usps > li::before { background-image: url("data:image/svg+xml,%3csvg viewbox='0 0 100 100' xmlns='http://www.w3.org/2000/svg' fill='%230070a8'%3e%3ccircle cx='50' cy='50' r='50'/%3e%3c/svg%3e"); } institutional subscriptions .sprcom-buybox-articledarwin .buybox__access-option{ border-top: 1px solid #cedbe0; font-size: 1rem; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus{ background-color: #ebf6ff; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus-headline{ display: flex; justify-content: space-between; } .sprcom-buybox-articledarwin .springer-plus-heading{ border-bottom: 1px solid #c5e0f4; border-top: 1px solid #c5e0f4; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; font-size: 1.125rem; font-weight: 700; margin: 0; padding: 16px; text-align: center; } .sprcom-buybox-articledarwin .springer-plus-title{ align-items: center; display: flex; } .sprcom-buybox-articledarwin .springer-plus-title span{ margin-left: 8px; } .sprcom-buybox-articledarwin .springer-plus a{ background-color: #fff; border: 1px solid #025e8d; color: #025e8d; font-size: 16px; font-weight: 700; max-height: 44px; } .sprcom-buybox-articledarwin .springer-plus a span{ margin-right: 8px; } .sprcom-buybox-articledarwin .springer-plus a:hover{ background-color: #025e8d; border: 4px solid #025e8d; box-shadow: none; color: #fff; font-weight: 700; } .sprcom-buybox-articledarwin .springer-plus a:visited{ color: #025e8d; } .sprcom-buybox-articledarwin .springer-plus a:visited:hover{ color: #fff; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps{ color: #555; font-size: 1rem; line-height: 1.6; list-style: none; margin: 0; padding: 16px 0 24px 0; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li{ padding-left: 26px; position: relative; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li::before{ content: ''; height: 10px; left: 0; position: absolute; top: calc(0.8em - 5px); width: 10px; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li:not(:first-child){ margin-top: 4px; } advertisement window.sn = window.sn || {}; window.sn.libs = window.sn.libs || {}; window.sn.libs.ads = window.sn.libs.ads || {}; window.sn.libs.ads.slotconfig = window.sn.libs.ads.slotconfig || {}; window.sn.libs.ads.slotconfig['mpu1'] = { 'pos': 'mpu1', 'type': 'mpu1', }; window.sn.libs.ads.slotconfig['unitpath'] = '/270604982/springerlink/213/article'; search search by keyword or author search navigation find a journal publish with us track your research discover content journals a-z books a-z publish with us journal finder publish your research language editing open access publishing products and services our products librarians societies partners and advertisers our brands springer nature portfolio bmc palgrave macmillan apress discover your privacy choices/manage cookies your us state privacy rights accessibility statement terms and conditions privacy policy help and support legal notice cancel contracts here 52.88.153.61 not affiliated &copy; 2025 springer nature

## Discussion
136. https://doi.org/10.2165/00148581-200709020-00007 article pubmed google scholar blum k, chen alc, braverman er, comings de, chen tjh, arcuri v, blum sh, downs bw, waite rl, notaro a, lubar j, williams l, prihoda tj, palomo t, oscar-berman m (2008) attention-deficit-hyperactivity disorder and reward deficiency syndrome. neuropsychiatr dis treat 4:893–918. https://doi.org/10.2147/ndt.s2627 article pubmed pubmed central google scholar bristot g, ascoli bm, scotton e, géa lp, pfaffenseller b, kauer-sant’anna m (2019) effects of lithium on inflammatory and neurotrophic factors after an immune challenge in a lisdexamfetamine animal model of mania. braz j psychiatry 41:419–427. https://doi.org/10.1590/1516-4446-2017-0001 article pubmed pubmed central google scholar burns c, kidron a (eds) (2022) biochemistry, tyramine. statpearls. internet. in: statpearls publishing, treasure island (fl), p 2024 jan-. https://www.ncbi.nlm.nih.gov/books/nbk563197/ comiran e, kessler fh, fröehlich pe, limberger rp (2016) lisdexamfetamine: a pharmacokinetic review. eur j pharm sci 89:172–179. https://doi.org/10.1016/j.ejps.2016.04.026 article cas pubmed google scholar crooks pa, zheng g, vartak ap, culver jp, zheng f, horton db, dwoskin lp (2011) design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse. curr top med chem 11:1103–1127. https://doi.org/10.2174/156802611795371332 article cas pubmed pubmed central google scholar dhillon s, yang lph, curran mp (2008) bupropion: a review of its use in the management of major depressive disorder. drugs 68:653–689. https://doi.org/10.2165/00003495-200868050-00011 article cas pubmed google scholar di miceli m, derf a, gronier b (2022) consequences of acute or chronic methylphenidate exposure using ex vivo neurochemistry and in vivo electrophysiology in the prefrontal cortex and striatum of rats. int j mol sci 23:8588. https://doi.org/10.3390/ijms23158588 article cas pubmed pubmed central google scholar dupaul gj, weyandt ll, rossi js, vilardo ba, o’dell sm, carson km, verdi g, swentosky a (2012) double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with adhd. j atten disord 16:202–220. https://doi.org/10.1177/1087054711427299 article pubmed google scholar duvall mg, levy bd (2016) dha- and epa-derived resolvins, protectins, and maresins in airway inflammation. eur j pharmacol 785:144–155. https://doi.org/10.1016/j.ejphar.2015.11.001 article cas pubmed google scholar eiden le, weihe e (2011) vmat2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. ann n y acad sci 1216:86–98. https://doi.org/10.1111/j.1749-6632.2010.05906.x article cas pubmed pubmed central google scholar fda (2017) mydayis. https://pi.shirecontent.com/pi/pdfs/mydayis_usa_eng.pdf fda (2009) ritalin. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/010187s077lbl.pdf foley kf, desanty kp, kast re (2006) bupropion: pharmacology and therapeutic applications. expert rev neurother 6:1249–1265. https://doi.org/10.1586/14737175.6.9.1249 article cas pubmed google scholar freyberg z, sonders ms, aguilar ji, hiranita t, karam cs, flores j, pizzo ab, zhang y, farino zj, chen a, martin ca, kopajtic ta, fei h, hu g, lin yy, mosharov ev, mccabe bd, freyberg r, wimalasena k, hsin lw, sames d, krantz de, katz jl, sulzer d, javitch ja (2016) mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in drosophila brain. nat commun 7:10652. https://doi.org/10.1038/ncomms10652 article cas pubmed pubmed central google scholar garey jd, lusskin si, scialli ar (2020) teratogen update: amphetamines. birth defects res 112:1171–1182. https://doi.org/10.1002/bdr2.1774 article cas pubmed google scholar guillot ts, miller gw (2009) protective actions of the vesicular monoamine transporter 2 (vmat2) in monoaminergic neurons. mol neurobiol 39:149–170. https://doi.org/10.1007/s12035-009-8059-y article cas pubmed google scholar guillot ts, richardson jr, wang mz, li yj, taylor tn, ciliax bj, zachrisson o, mercer a, miller gw (2008) pacap38 increases vesicular monoamine transporter 2 (vmat2) expression and attenuates methamphetamine toxicity. neuropeptides 42:423–434. https://doi.org/10.1016/j.npep.2008.04.003 article cas pubmed pubmed central google scholar hauser j, makulska-gertruda e, reissmann a, sontag ta, tucha o, lange kw (2014) the effects of nutritional polyunsaturated fatty acids on locomotor activity in spontaneously hypertensive rats. atten defic hyperact disord 6:61–65. https://doi.org/10.1007/s12402-013-0125-7 article pubmed google scholar healy-stoffel m, levant b (2018) n-3 (omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders. cns neurol disord drug targets 17:216–232. https://doi.org/10.2174/1871527317666180412153612 article cas pubmed pubmed central google scholar heinzerling kg, swanson an, hall tm, yi y, wu y, shoptaw sj (2014) randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use. addiction 109:1878–1886. https://doi.org/10.1111/add.12636 article pubmed pubmed central google scholar hesse lm, venkatakrishnan k, court mh, von moltke ll, duan sx, shader ri, greenblatt dj (2000) cyp2b6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. drug metab dispos 28:1176–1183 cas pubmed google scholar huss m, duhan p, gandhi p, chen cw, spannhuth c, kumar v (2017) methylphenidate dose optimization for adhd treatment: review of safety, efficacy, and clinical necessity. neuropsychiatr dis treat 13:1741–1751. https://doi.org/10.2147/ndt.s130444 article cas pubmed pubmed central google scholar hutson ph, pennick m, secker r (2014) preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug. neuropharmacology 87:41–50. https://doi.org/10.1016/j.neuropharm.2014.02.014 article cas pubmed google scholar iwahashi m, yoshimura t, harigai w, takuma k, hashimoto h, katayama t, hayata-takano a (2023) pituitary adenylate cyclase-activating polypeptide deficient mice show length abnormalities of the axon initial segment. j pharmacol sci 153:175–182. https://doi.org/10.1016/j.jphs.2023.08.006 article cas pubmed google scholar kameg b, fradkin d (2021) management of attention-deficit/hyperactivity disorder in adults. j nurse pract 17:432–436. https://doi.org/10.1016/j.nurpra.2020.11.005 article google scholar kazda l, bell k, thomas r, mcgeechan k, sims r, barratt a (2021) overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic scoping review. jama netw open 4:e215335. https://doi.org/10.1001/jamanetworkopen.2021.5335 article pubmed pubmed central google scholar korchynska s, rebernik p, pende m, boi l, alpár a, tasan r, becker k, balueva k, saghafi s, wulff p, horvath tl, fisone g, dodt hu, hökfelt t, harkany t, romanov ra (2022) a hypothalamic dopamine locus for psychostimulant-induced hyperlocomotion in mice. nat commun 13:5944. https://doi.org/10.1038/s41467-022-33584-3 article cas pubmed pubmed central google scholar li y, yan x, li q, li q, xu g, lu j, yang w (2023) prevalence and trends in diagnosed adhd among us children and adolescents, 2017–2022. jama netw open 6:e2336872. https://doi.org/10.1001/jamanetworkopen.2023.36872 article pubmed pubmed central google scholar lu w, wolf me (1997) expression of dopamine transporter and vesicular monoamine transporter 2 mrnas in rat midbrain after repeated amphetamine administration. brain res mol brain res 49:137–148. https://doi.org/10.1016/s0169-328x(97)00136-8 article cas pubmed google scholar majarwitz dj, perumareddi p (2023) attention-deficit/hyperactivity disorder across the spectrum: from childhood to adulthood. prim care 50:21–36. https://doi.org/10.1016/j.pop.2022.10.004 article pubmed google scholar maneeton n, maneeton b, srisurapanont m, martin sd (2011) bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo‐controlled trials. psychiatry clin neurosci 65:611–617. https://doi.org/10.1111/j.1440-1819.2011.02264.x article pubmed google scholar martin ca, nuzzo pa, ranseen jd, kleven ms, guenthner g, williams y, walsh sl, dwoskin lp (2018) lobeline effects on cognitive performance in adult adhd. j atten disord 22:1361–1366. https://doi.org/10.1177/1087054713497791 article pubmed google scholar metz vg, segat hj, dias vt, barcelos rcs, maurer lh, stiebe j, emanuelli t, burger me, pase cs (2019) omega-3 decreases d1 and d2 receptors expression in the prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats. j nutr biochem 67:182–189. https://doi.org/10.1016/j.jnutbio.2019.02.007 article cas pubmed google scholar najib j (2009) the efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults. clin ther 31:142–176. https://doi.org/10.1016/j.clinthera.2009.01.015 article cas pubmed google scholar najib j, wimer d, zeng j, lam kw, romanyak n, paige morgan e, thadavila a (2017) review of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. j cent nerv syst dis 9:1179573517728090. https://doi.org/10.1177/1179573517728090 article cas pubmed pubmed central google scholar narendran r, frankle wg, mason ns, muldoon mf, moghaddam b (2012) improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation. plos one 7:e46832. https://doi.org/10.1371/journal.pone.0046832 article cas pubmed pubmed central google scholar ng qx (2017) a systematic review of the use of bupropion for attention-deficit/hyperactivity disorder in children and adolescents. j child adolesc psychopharmacol 27:112–116. https://doi.org/10.1089/cap.2016.0124 article cas pubmed google scholar nguyen m, shapiro ma, tharani s (2012) clinical utility of lisdexamfetamine for the management of attention-deficit hyperactivity disorder. clin med insights ther 4. https://doi.org/10.4137/cmt.s8706 nickell jr, siripurapu kb, vartak a, crooks pa, dwoskin lp (2014) the vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. adv pharmacol 69:71–106. https://doi.org/10.1016/b978-0-12-420118-7.00002-0 article cas pubmed pubmed central google scholar partilla js, dempsey ag, nagpal as, blough be, baumann mh, rothman rb (2006) interaction of amphetamines and related compounds at the vesicular monoamine transporter. j pharmacol exp ther 319:237–246. https://doi.org/10.1124/jpet.106.103622 article cas pubmed google scholar perera h, jeewandara kc, seneviratne s, guruge c (2012) combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (adhd) refractory to methylphenidate treatment: a double-blind, placebo-controlled study. j child neurol 27:747–753. https://doi.org/10.1177/0883073811435243 article pubmed google scholar quintero j, gutiérrez-casares jr, álamo c (2022) molecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on adhd neurobiology: a review. neurol ther 11:1489–1517. https://doi.org/10.1007/s40120-022-00392-2 article pubmed pubmed central google scholar rau ks, birdsall e, hanson je, johnson-davis kl, carroll fi, wilkins dg, gibb jw, hanson gr, fleckenstein ae (2005) bupropion increases striatal vesicular monoamine transport. neuropharmacology 49:820–830. https://doi.org/10.1016/j.neuropharm.2005.05.004 article cas pubmed google scholar reese mj, wurm rm, muir kt, generaux gt, st john-williams l, mcconn dj (2008) an in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug–drug interaction. drug metab dispos 36:1198–1201. https://doi.org/10.1124/dmd.107.020198 article cas pubmed google scholar riddle el, hanson gr, fleckenstein ae (2007) therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. eur j pharmacol 571:25–28. https://doi.org/10.1016/j.ejphar.2007.05.044 article cas pubmed pubmed central google scholar sandoval v, riddle el, hanson gr, fleckenstein ae (2002) methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. j neurosci 22:8705–8710. https://doi.org/10.1523/jneurosci.22-19-08705.2002 article cas pubmed pubmed central google scholar schwartz k, weizman a, rehavi m (2006) the effect of psychostimulants on [ 3 h]dopamine uptake and release in rat brain synaptic vesicles. j neural transm (vienna) 113:1347–1352. https://doi.org/10.1007/s00702-005-0383-4 article cas pubmed google scholar stahl sm (2014) stahl’s essential psychopharmacology. cambridge stahl sm, pradko jf, haight br, modell jg, rockett cb, learned-coughlin s (2004) a review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. prim care companion j clin psychiatry 6:159–166. https://doi.org/10.4088/pcc.v06n0403 article pubmed pubmed central google scholar støier jf, konomi-pilkati a, apuschkin m, herborg f, gether u (2023) amphetamine-induced reverse transport of dopamine does not require cytosolic ca 2+ . j biol chem 299:105063. https://doi.org/10.1016/j.jbc.2023.105063 article cas pubmed pubmed central google scholar strawn jr, picard ls (2017) triple-bead mixed amphetamine salt for adhd. curr psychiatry 16:33–37 google scholar sulzer d, rayport s (1990) amphetamine and other psychostimulants reduce ph gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. neuron 5:797–808. https://doi.org/10.1016/0896-6273(90)90339-h article cas pubmed google scholar teng lh, crooks pa, sonsalla pk, dwoskin lp (1997) lobeline and nicotine evoke [ 3 h]overflow from rat striatal slices preloaded with [ 3 h]dopamine: differential inhibition of synaptosomal and vesicular [ 3 h]dopamine uptake. j pharmacol exp ther 280:1432–1444 cas pubmed google scholar teng b, murthy ks, kuemmerle jf, grider jr, makhlouf gm (1998) selective expression of vasoactive intestinal peptide (vip)2/pituitary adenylate cyclase-activating polypeptide (pacap)3 receptors in rabbit and guinea pig gastric and tenia coli smooth muscle cells. regul pept 77:127–134. https://doi.org/10.1016/s0167-0115(98)00112-8 article cas pubmed google scholar toren p, rehavi m, luski a, roz n, laor n, lask m, weizman a (2005) decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder. eur neuropsychopharmacol 15:159–162. https://doi.org/10.1016/j.euroneuro.2004.07.002 article cas pubmed google scholar vaudry d, gonzalez bj, basille m, yon l, fournier a, vaudry h (2000) pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. pharmacol rev 52:269–324 cas pubmed google scholar velasco er, florido a, flores á, senabre e, gomez-gomez a, torres a, roca a, norrholm s, newman el, das p, ross ra, lori a, pozo oj, ressler kj, garcia-esteve ll, jovanovic t, andero r (2022) pacap-pac1r modulates fear extinction via the ventromedial hypothalamus. nat commun 13:4374. https://doi.org/10.1038/s41467-022-31442-w article cas pubmed pubmed central google scholar verbeeck w, bekkering ge, van den noortgate w, kramers c (2017) bupropion for attention deficit hyperactivity disorder (adhd) in adults. cochrane database syst rev 10:cd009504. https://doi.org/10.1002/14651858.cd009504.pub2 article pubmed google scholar wang g, pan j, tan yy, sun xk, zhang yf, zhou hy, ren rj, wang xj, chen sd (2008) neuroprotective effects of pacap27 in mice model of parkinson’s disease involved in the modulation of k(atp) subunits and d2 receptors in the striatum. neuropeptides 42:267–276. https://doi.org/10.1016/j.npep.2008.03.002 article cas pubmed google scholar wimalasena k (2011) vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry. med res rev 31:483–519. https://doi.org/10.1002/med.20187 article cas pubmed google scholar download references acknowledgements we thank editage ( www.editage.com ) for english language editing. funding not applicable. author information authors and affiliations dr. kiran c. patel college of osteopathic medicine, dr. kiran c. patel college of osteopathic medicine, nova southeastern university, fort lauderdale, fort lauderdale, florida, usa halford warlick iv, sukriti prashar, erick boldt, alena khalil, simran arora, thomas matthews, talha wahid, richard fernandez, dhiya ram &amp; lexie leon dr. kiran c. patel college of allopathic medicine, health profession division, nova southeastern university, fort lauderdale, florida, usa darcy tocci &amp; kelley davis college of pharmacy, health profession division, nova southeastern university, fort lauderdale, florida, usa jose rey halmos college of arts and sciences, nova southeastern university, fort lauderdale, florida, usa arisha arain authors halford warlick iv view author publications search author on: pubmed google scholar darcy tocci view author publications search author on: pubmed google scholar sukriti prashar view author publications search author on: pubmed google scholar erick boldt view author publications search author on: pubmed google scholar alena khalil view author publications search author on: pubmed google scholar simran arora view author publications search author on: pubmed google scholar thomas matthews view author publications search author on: pubmed google scholar talha wahid view author publications search author on: pubmed google scholar richard fernandez view author publications search author on: pubmed google scholar dhiya ram view author publications search author on: pubmed google scholar lexie leon view author publications search author on: pubmed google scholar arisha arain view author publications search author on: pubmed google scholar jose rey view author publications search author on: pubmed google scholar kelley davis view author publications search author on: pubmed google scholar corresponding author correspondence to halford warlick iv . ethics declarations conflict of interest not applicable. additional information publisher’s note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. rights and permissions springer nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. reprints and permissions about this article cite this article warlick iv, h., tocci, d., prashar, s. et al. role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review. psychopharmacology 241 , 2191–2203 (2024). https://doi.org/10.1007/s00213-024-06686-7 download citation received : 19 january 2024 accepted : 05 september 2024 published : 20 september 2024 issue date : november 2024 doi : https://doi.org/10.1007/s00213-024-06686-7 share this article anyone you share the following link with will be able to read this content: get shareable link sorry, a shareable link is not currently available for this article. copy shareable link to clipboard provided by the springer nature sharedit content-sharing initiative keywords attention deficit hyperactivity disorder vesicular monoamine transporter neurodevelopmental disorder amphetamines methylphenidate omega-3 fatty acids bupropion norepinephrine dopamine ph gradient model profiles halford warlick iv view author profile access this article log in via an institution subscribe and save springer+ from $39.99 /month starting from 10 chapters or articles per month access and download chapters and articles from more than 300k books and 2,500 journals cancel anytime view plans buy now buy article pdf usd 39.95 price excludes vat (usa) tax calculation will be finalised during checkout. instant access to the full article pdf. datalayer.push({"ecommerce":{"currency":"usd","impressions":[{"name":"role of vesicular monoamine transporter-2 for treating attention deficit hyperactivity disorder: a review","id":"1432-2072","price":39.95,"brand":"springer berlin heidelberg","category":"neuroscience","variant":"ppv-article","quantity":1}]}}); ;(function () { if (window.localstorage) { window.localstorage.removeitem("springerplusrollout") } })() .springer-plus .buying-option-usps > li::before { background-image: url("data:image/svg+xml,%3csvg viewbox='0 0 100 100' xmlns='http://www.w3.org/2000/svg' fill='%230070a8'%3e%3ccircle cx='50' cy='50' r='50'/%3e%3c/svg%3e"); } institutional subscriptions .sprcom-buybox-articledarwin .buybox__access-option{ border-top: 1px solid #cedbe0; font-size: 1rem; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus{ background-color: #ebf6ff; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; padding: 16px; } .sprcom-buybox-articledarwin .springer-plus-headline{ display: flex; justify-content: space-between; } .sprcom-buybox-articledarwin .springer-plus-heading{ border-bottom: 1px solid #c5e0f4; border-top: 1px solid #c5e0f4; font-family: 'merriweather sans', 'helvetica neue', helvetica, arial, sans-serif; font-size: 1.125rem; font-weight: 700; margin: 0; padding: 16px; text-align: center; } .sprcom-buybox-articledarwin .springer-plus-title{ align-items: center; display: flex; } .sprcom-buybox-articledarwin .springer-plus-title span{ margin-left: 8px; } .sprcom-buybox-articledarwin .springer-plus a{ background-color: #fff; border: 1px solid #025e8d; color: #025e8d; font-size: 16px; font-weight: 700; max-height: 44px; } .sprcom-buybox-articledarwin .springer-plus a span{ margin-right: 8px; } .sprcom-buybox-articledarwin .springer-plus a:hover{ background-color: #025e8d; border: 4px solid #025e8d; box-shadow: none; color: #fff; font-weight: 700; } .sprcom-buybox-articledarwin .springer-plus a:visited{ color: #025e8d; } .sprcom-buybox-articledarwin .springer-plus a:visited:hover{ color: #fff; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps{ color: #555; font-size: 1rem; line-height: 1.6; list-style: none; margin: 0; padding: 16px 0 24px 0; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li{ padding-left: 26px; position: relative; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li::before{ content: ''; height: 10px; left: 0; position: absolute; top: calc(0.8em - 5px); width: 10px; } .sprcom-buybox-articledarwin .springer-plus .buying-option-usps > li:not(:first-child){ margin-top: 4px; } advertisement window.sn = window.sn || {}; window.sn.libs = window.sn.libs || {}; window.sn.libs.ads = window.sn.libs.ads || {}; window.sn.libs.ads.slotconfig = window.sn.libs.ads.slotconfig || {}; window.sn.libs.ads.slotconfig['mpu1'] = { 'pos': 'mpu1', 'type': 'mpu1', }; window.sn.libs.ads.slotconfig['unitpath'] = '/270604982/springerlink/213/article'; search search by keyword or author search navigation find a journal publish with us track your research discover content journals a-z books a-z publish with us journal finder publish your research language editing open access publishing products and services our products librarians societies partners and advertisers our brands springer nature portfolio bmc palgrave macmillan apress discover your privacy choices/manage cookies your us state privacy rights accessibility statement terms and conditions privacy policy help and support legal notice cancel contracts here 52.88.153.61 not affiliated &copy; 2025 springer nature

## Scraping Notes

- Successfully scraped from DOI.org
